The	O
DNA	B-protein
binding	I-protein
domain	I-protein
of	O
the	O
A-MYB	B-protein
transcription	B-protein
factor	I-protein
is	O
responsible	O
for	O
its	O
B	O
cell-specific	O
activity	O
and	O
binds	O
to	O
a	O
B	B-protein
cell	I-protein
110-kDa	I-protein
nuclear	I-protein
protein	I-protein
.	O

Expression	O
studies	O
as	O
well	O
as	O
the	O
use	O
of	O
transgenic	O
animals	O
have	O
demonstrated	O
that	O
the	O
A-MYB	B-protein
transcription	B-protein
factor	I-protein
plays	O
central	O
and	O
specific	O
role	O
in	O
the	O
regulation	O
of	O
mature	B-cell_type
B	I-cell_type
cell	I-cell_type
proliferation	O
and/or	O
differentiation	O
.	O

Furthermore	O
,	O
it	O
is	O
highly	O
expressed	O
in	O
Burkitt	B-cell_line
's	I-cell_line
lymphoma	I-cell_line
cells	I-cell_line
and	O
may	O
participate	O
in	O
the	O
pathogenesis	O
of	O
this	O
disease	O
.	O

We	O
have	O
therefore	O
investigated	O
the	O
transcriptional	O
activity	O
of	O
A-MYB	B-protein
and	O
its	O
regulation	O
in	O
several	O
human	B-cell_line
lymphoid	I-cell_line
cell	I-cell_line
lines	I-cell_line
using	O
co-transfection	O
assays	O
and	O
show	O
that	O
A-MYB	B-protein
is	O
transcriptionally	O
active	O
in	O
all	O
the	O
B	B-cell_line
cell	I-cell_line
lines	I-cell_line
studied	O
,	O
but	O
not	O
in	O
T	B-cell_type
cells	I-cell_type
.	O

In	O
particular	O
the	O
best	O
responder	B-cell_line
cell	I-cell_line
line	I-cell_line
was	O
the	O
Burkitt	B-cell_line
's	I-cell_line
cell	I-cell_line
line	I-cell_line
Namalwa	I-cell_line
.	O

The	O
activity	O
of	O
A-MYB	B-protein
in	O
B	B-cell_type
and	I-cell_type
not	I-cell_type
T	I-cell_type
cells	I-cell_type
was	O
observed	O
when	O
either	O
an	O
artificial	O
construct	O
or	O
the	O
c-MYC	B-DNA
promoter	I-DNA
was	O
used	O
as	O
a	O
reporter	O
.	O

Furthermore	O
,	O
the	O
functional	B-protein
domains	I-protein
responsible	O
for	O
DNA	O
binding	O
,	O
transactivation	O
,	O
and	O
negative	O
regulation	O
,	O
previously	O
characterized	O
in	O
a	O
fibroblast	O
context	O
,	O
were	O
found	O
to	O
have	O
similar	O
activity	O
in	O
B	B-cell_type
cells	I-cell_type
.	O

The	O
region	O
of	O
A-MYB	B-protein
responsible	O
for	O
the	O
B	O
cell	O
specific	O
activity	O
was	O
defined	O
to	O
be	O
the	O
N-terminal	B-protein
218	I-protein
amino	I-protein
acids	I-protein
containing	O
the	O
DNA	B-protein
binding	I-protein
domain	I-protein
.	O

Finally	O
,	O
a	O
110-kDa	B-protein
protein	I-protein
has	O
been	O
identified	O
in	O
the	O
nuclei	O
of	O
all	O
the	O
B	B-cell_line
,	I-cell_line
but	I-cell_line
not	I-cell_line
T	I-cell_line
,	I-cell_line
cell	I-cell_line
lines	I-cell_line
that	O
specifically	O
binds	O
to	O
this	O
A-MYB	B-protein
N-terminal	I-protein
domain	I-protein
.	O

We	O
hypothesize	O
that	O
this	O
110-kDa	B-protein
protein	I-protein
may	O
be	O
a	O
functionally	O
important	O
B	B-protein
cell-specific	I-protein
co-activator	I-protein
of	O
A-MYB	B-protein
.	O

THE	NULL
JOURNAL	NULL
or	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
©	NULL
1997	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

272	NULL
,	NULL
No	NULL
.	NULL

40	NULL
,	NULL
Issue	NULL
of	NULL
October	NULL
3	NULL
,	NULL
pp	NULL
.	NULL

24921-24926	NULL
,	NULL
1997	NULL
Printed	NULL
in	NULL
U.S.A	NULL
.	NULL

The	NULL
DNA	NULL
Binding	NULL
Domain	NULL
of	NULL
the	NULL
A-MYB	NULL
Transcription	NULL
Factor	NULL
Is	NULL
Responsible	NULL
for	NULL
Its	NULL
B	NULL
Cell-specific	NULL
Activity	NULL
and	NULL
Binds	NULL
to	NULL
a	NULL
B	NULL
Cell	NULL
110-kDa	NULL
Nuclear	NULL
Protein*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
May	NULL
7	NULL
,	NULL
1997	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
June	NULL
24	NULL
,	NULL
1997	NULL
)	NULL
Guo-Guang	NULL
Yingt	NULL
,	NULL
Marcello	NULL
Arsuraf§	NULL
,	NULL
Martino	NULL
Introna	NULL
#	NULL
1	NULL
,	NULL
and	NULL
Josée	NULL
Golay	NULL
#	NULL
|	NULL
From	NULL
the	NULL
{	NULL
Laboratory	NULL
of	NULL
Molecular	NULL
Immunohematology	NULL
,	NULL
Department	NULL
of	NULL
Immunology	NULL
and	NULL
Cell	NULL
Biology	NULL
,	NULL
Istituto	NULL
Ricerche	NULL
Farmacologiche	NULL
``	NULL
Mario	NULL
Negri	NULL
,	NULL
``	NULL
via	NULL
Eritrea	NULL
62	NULL
,	NULL
20157	NULL
Milano	NULL
,	NULL
Italy	NULL
and	NULL
the	NULL
§Department	NULL
of	NULL
Biochemistry	NULL
,	NULL
Boston	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Boston	NULL
,	NULL
Massachusetts	NULL
02118-2394	NULL
Expression	NULL
studies	NULL
as	NULL
well	NULL
as	NULL
the	NULL
use	NULL
of	NULL
transgenic	NULL
animals	NULL
have	NULL
demonstrated	NULL
that	NULL
the	NULL
A-MYB	NULL
transcription	NULL
factor	NULL
plays	NULL
central	NULL
and	NULL
specific	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
mature	NULL
B	NULL
cell	NULL
proliferation	NULL
and/or	NULL
differentiation	NULL
.	NULL

Furthermore	NULL
,	NULL
it	NULL
is	NULL
highly	NULL
expressed	NULL
in	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cells	NULL
and	NULL
may	NULL
participate	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
this	NULL
disease	NULL
.	NULL

We	NULL
have	NULL
therefore	NULL
investigated	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
A-MYB	NULL
and	NULL
its	NULL
regulation	NULL
in	NULL
several	NULL
human	NULL
lymphoid	NULL
cell	NULL
lines	NULL
using	NULL
co-transfection	NULL
assays	NULL
and	NULL
show	NULL
that	NULL
A-MYB	NULL
is	NULL
transcriptionally	NULL
active	NULL
in	NULL
all	NULL
the	NULL
B	NULL
cell	NULL
lines	NULL
studied	NULL
,	NULL
but	NULL
not	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
particular	NULL
the	NULL
best	NULL
responder	NULL
cell	NULL
line	NULL
was	NULL
the	NULL
Burkitt	NULL
's	NULL
cell	NULL
line	NULL
Namalwa	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
A-MYB	NULL
in	NULL
B	NULL
and	NULL
not	NULL
T	NULL
cells	NULL
was	NULL
observed	NULL
when	NULL
either	NULL
an	NULL
artificial	NULL
construct	NULL
or	NULL
the	NULL
c-MYC	NULL
promoter	NULL
was	NULL
used	NULL
as	NULL
a	NULL
reporter	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
functional	NULL
domains	NULL
responsible	NULL
for	NULL
DNA	NULL
binding	NULL
,	NULL
transactivation	NULL
,	NULL
and	NULL
negative	NULL
regulation	NULL
,	NULL
previously	NULL
characterized	NULL
in	NULL
a	NULL
fibroblast	NULL
context	NULL
,	NULL
were	NULL
found	NULL
to	NULL
have	NULL
similar	NULL
activity	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

The	NULL
region	NULL
of	NULL
A-MYB	NULL
responsible	NULL
for	NULL
the	NULL
B	NULL
cell	NULL
specific	NULL
activity	NULL
was	NULL
defined	NULL
to	NULL
be	NULL
the	NULL
N-terminal	NULL
218	NULL
amino	NULL
acids	NULL
containing	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
.	NULL

Finally	NULL
,	NULL
a	NULL
110-kDa	NULL
protein	NULL
has	NULL
been	NULL
identified	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
all	NULL
the	NULL
B	NULL
,	NULL
but	NULL
not	NULL
T	NULL
,	NULL
cell	NULL
lines	NULL
that	NULL
specifically	NULL
binds	NULL
to	NULL
this	NULL
A-MYB	NULL
N-terminal	NULL
domain	NULL
.	NULL

We	NULL
hypothesize	NULL
that	NULL
this	NULL
110-kDa	NULL
protein	NULL
may	NULL
be	NULL
a	NULL
functionally	NULL
important	NULL
B	NULL
cell-specific	NULL
co-activator	NULL
of	NULL
A-MYB	NULL
.	NULL

Transcription	NULL
factors	NULL
control	NULL
crucial	NULL
cellular	NULL
processes	NULL
such	NULL
as	NULL
cell	NULL
growth	NULL
and	NULL
differentiation	NULL
.	NULL

Deregulation	NULL
of	NULL
their	NULL
function	NULL
or	NULL
of	NULL
their	NULL
expression	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
many	NULL
hematopoietic	NULL
neoplasms	NULL
(	NULL
1	NULL
)	NULL
.	NULL

A-MYB	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
Myb	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
(	NULL
2-4	NULL
)	NULL
.	NULL

All	NULL
members	NULL
of	NULL
the	NULL
Myb	NULL
family	NULL
have	NULL
been	NULL
implicated	NULL
directly	NULL
in	NULL
the	NULL
control	NULL
of	NULL
cell	NULL
growth	NULL
and	NULL
differentiation	NULL
(	NULL
reviewed	NULL
in	NULL
Refs	NULL
.	NULL

3	NULL
and	NULL
4	NULL
)	NULL
:	NULL
the	NULL
v-MYB	NULL
oncogene	NULL
transforms	NULL
cells	NULL
of	NULL
hematopoietic	NULL
origin	NULL
(	NULL
5	NULL
)	NULL
,	NULL
its	NULL
normal	NULL
cellular	NULL
equivalent	NULL
c-MYB	NULL
is	NULL
required	NULL
for	NULL
hemopoiesis	NULL
(	NULL
6	NULL
)	NULL
and	NULL
B-MYB	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
proliferation	NULL
and	NULL
differentiation	NULL
of	NULL
many	NULL
lineages	NULL
(	NULL
7-9	NULL
)	NULL
.	NULL

Finally	NULL
A-MYB	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
restricted	NULL
*This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
Italian	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
(	NULL
AIRC	NULL
)	NULL
and	NULL
the	NULL
National	NULL
Research	NULL
Council	NULL
(	NULL
CNR	NULL
Rome	NULL
,	NULL
Project	NULL
ACRO	NULL
)	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

|	NULL
Supported	NULL
by	NULL
the	NULL
Cure	NULL
for	NULL
Lymphoma	NULL
Foundation	NULL
,	NULL
New	NULL
York	NULL
.	NULL

To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Head	NULL
of	NULL
the	NULL
Molecular	NULL
Immunohematology	NULL
Laboratory	NULL
,	NULL
Dept	NULL
.	NULL

of	NULL
Immunology	NULL
and	NULL
Cell	NULL
Biology	NULL
,	NULL
Istituto	NULL
di	NULL
Ricerche	NULL
Farmacologiche	NULL
``	NULL
Mario	NULL
Negri	NULL
,	NULL
``	NULL
via	NULL
Eritrea	NULL
,	NULL
62	NULL
20157	NULL
Milano	NULL
,	NULL
Italy	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
89-2-89014547	NULL
;	NULL
fax	NULL
:	NULL
89-2-883200281	NULL
;	NULL
E-mail	NULL
:	NULL
martino	NULL
@	NULL
irfmn.mnegri.it	NULL
.	NULL

|	NULL
Supported	NULL
by	NULL
the	NULL
Associazione	NULL
Valenti	NULL
.	NULL

This	NULL
paper	NULL
is	NULL
available	NULL
on	NULL
line	NULL
at	NULL
http	NULL
:	NULL
//www.jbc.org	NULL
lineages	NULL
and	NULL
during	NULL
a	NULL
specific	NULL
stage	NULL
of	NULL
their	NULL
differentiation	NULL
.	NULL

Among	NULL
hematopoietic	NULL
cells	NULL
,	NULL
A-MYB	NULL
expression	NULL
is	NULL
restricted	NULL
to	NULL
a	NULL
narrow	NULL
window	NULL
of	NULL
normal	NULL
B	NULL
cell	NULL
differentiation	NULL
,	NULL
taking	NULL
place	NULL
in	NULL
germinal	NULL
centers	NULL
(	NULL
10	NULL
,	NULL
11	NULL
)	NULL
.	NULL

Furthermore	NULL
it	NULL
is	NULL
highly	NULL
expressed	NULL
in	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
(	NULL
BL	NULL
)	NULL
cells	NULL
and	NULL
not	NULL
in	NULL
most	NULL
other	NULL
neoplas-tic	NULL
B	NULL
cells	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Very	NULL
recently	NULL
,	NULL
transgenic	NULL
mice	NULL
expressing	NULL
high	NULL
levels	NULL
of	NULL
ectopic	NULL
A-MYB	NULL
in	NULL
most	NULL
tissues	NULL
have	NULL
been	NULL
found	NULL
to	NULL
show	NULL
follicular	NULL
hyperplasia	NULL
and	NULL
enhanced	NULL
B	NULL
cell	NULL
proliferation	NULL
,	NULL
demonstrating	NULL
that	NULL
A-MYB	NULL
plays	NULL
an	NULL
important	NULL
and	NULL
specific	NULL
role	NULL
in	NULL
regulating	NULL
B	NULL
cell	NULL
proliferation	NULL
and/or	NULL
differentiation	NULL
(	NULL
13	NULL
)	NULL
.	NULL

These	NULL
data	NULL
as	NULL
well	NULL
as	NULL
its	NULL
ability	NULL
to	NULL
cooperate	NULL
with	NULL
c-MYC	NULL
in	NULL
promoting	NULL
entry	NULL
into	NULL
S	NULL
phase	NULL
(	NULL
14	NULL
)	NULL
strongly	NULL
suggest	NULL
that	NULL
it	NULL
is	NULL
an	NULL
important	NULL
factor	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
BL	NULL
(	NULL
12	NULL
,	NULL
13	NULL
)	NULL
.	NULL

A-MYB	NULL
is	NULL
expressed	NULL
in	NULL
few	NULL
other	NULL
nonhematopoietic	NULL
tissues	NULL
:	NULL
spermato-cytes	NULL
,	NULL
some	NULL
epithelial	NULL
cells	NULL
,	NULL
and	NULL
some	NULL
central	NULL
nervous	NULL
system	NULL
cells	NULL
(	NULL
2	NULL
,	NULL
11	NULL
,	NULL
15	NULL
)	NULL
.	NULL

A-MYB	NULL
knockout	NULL
mice	NULL
show	NULL
defects	NULL
in	NULL
sper-matogenesis	NULL
and	NULL
mammary	NULL
gland	NULL
formation	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
normal	NULL
expression	NULL
pattern	NULL
of	NULL
the	NULL
gene	NULL
(	NULL
16	NULL
)	NULL
.	NULL

The	NULL
transcriptional	NULL
activity	NULL
of	NULL
A-MYB	NULL
and	NULL
its	NULL
regulation	NULL
have	NULL
never	NULL
previously	NULL
been	NULL
investigated	NULL
in	NULL
B	NULL
lymphocytes	NULL
,	NULL
one	NULL
of	NULL
the	NULL
cellular	NULL
context	NULL
in	NULL
which	NULL
it	NULL
plays	NULL
an	NULL
important	NULL
function	NULL
.	NULL

Several	NULL
functional	NULL
and	NULL
regulatory	NULL
domains	NULL
of	NULL
human	NULL
A-MYB	NULL
have	NULL
been	NULL
recently	NULL
characterized	NULL
in	NULL
murine	NULL
fibroblasts	NULL
(	NULL
17	NULL
,	NULL
18	NULL
)	NULL
.	NULL

Amino	NULL
acids	NULL
33-188	NULL
contain	NULL
the	NULL
three	NULL
imperfect	NULL
repeats	NULL
of	NULL
51-52	NULL
aa	NULL
,	NULL
which	NULL
form	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
(	NULL
19	NULL
)	NULL
.	NULL

The	NULL
transactivation	NULL
domain	NULL
is	NULL
formed	NULL
by	NULL
about	NULL
100	NULL
aa	NULL
centered	NULL
around	NULL
a	NULL
stretch	NULL
of	NULL
charged	NULL
amino	NULL
acids	NULL
(	NULL
aa	NULL
218-318	NULL
)	NULL
.	NULL

The	NULL
C-terminal	NULL
half	NULL
of	NULL
the	NULL
molecule	NULL
is	NULL
inhibitory	NULL
for	NULL
both	NULL
DNA	NULL
binding	NULL
and	NULL
transactivation	NULL
(	NULL
17	NULL
,	NULL
18	NULL
)	NULL
.	NULL

In	NULL
this	NULL
report	NULL
we	NULL
have	NULL
set	NULL
out	NULL
to	NULL
investigate	NULL
the	NULL
activity	NULL
of	NULL
A-MYB	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

We	NULL
show	NULL
that	NULL
the	NULL
A-MYB	NULL
transcriptional	NULL
activity	NULL
can	NULL
be	NULL
detected	NULL
in	NULL
all	NULL
B	NULL
cell	NULL
lines	NULL
studied	NULL
,	NULL
being	NULL
the	NULL
highest	NULL
in	NULL
BL	NULL
cells	NULL
.	NULL

By	NULL
contrast	NULL
A-MYB	NULL
was	NULL
not	NULL
active	NULL
in	NULL
the	NULL
T	NULL
cell	NULL
lines	NULL
.	NULL

Furthermore	NULL
we	NULL
have	NULL
defined	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
A-MYB	NULL
as	NULL
being	NULL
responsible	NULL
for	NULL
its	NULL
B	NULL
cell	NULL
specific	NULL
activity	NULL
and	NULL
have	NULL
identified	NULL
a	NULL
110-kDa	NULL
protein	NULL
present	NULL
in	NULL
B	NULL
,	NULL
but	NULL
not	NULL
T	NULL
,	NULL
cells	NULL
that	NULL
is	NULL
able	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
A-MYB	NULL
DNA	NULL
binding	NULL
domain	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Cell	NULL
Lines	NULL
and	NULL
Cell	NULL
Cultures-The	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cell	NULL
line	NULL
Namalwa	NULL
was	NULL
a	NULL
kind	NULL
gift	NULL
of	NULL
Prof.	NULL
D.	NULL
H.	NULL
Crawford	NULL
(	NULL
London	NULL
School	NULL
of	NULL
Hygiene	NULL
and	NULL
Tropical	NULL
Medicine	NULL
,	NULL
London	NULL
)	NULL
.	NULL

The	NULL
myeloma	NULL
cell	NULL
line	NULL
IM-9	NULL
,	NULL
the	NULL
acute	NULL
lymphoblastic	NULL
T	NULL
leukemia	NULL
line	NULL
CEM	NULL
,	NULL
and	NULL
the	NULL
T	NULL
cell	NULL
leukemia	NULL
line	NULL
Jurkat	NULL
were	NULL
from	NULL
the	NULL
American	NULL
Tissue	NULL
Culture	NULL
Collection	NULL
(	NULL
ATCC	NULL
;	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

The	NULL
BJAB	NULL
non-Hodgkin	NULL
lymphoma	NULL
line	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
Dr.	NULL
Vercelli	NULL
,	NULL
Dibit	NULL
Center	NULL
,	NULL
Ospedale	NULL
San	NULL
Raffaele	NULL
,	NULL
Milan	NULL
,	NULL
Italy	NULL
)	NULL
.	NULL

All	NULL
lines	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
(	NULL
Seromed	NULL
,	NULL
Berlin	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
HyClone	NULL
,	NULL
Steril	NULL
System	NULL
,	NULL
Logan	NULL
,	NULL
UT	NULL
)	NULL
,	NULL
glutamine	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
,	NULL
Paisley	NULL
,	NULL
Scotland	NULL
)	NULL
,	NULL
and	NULL
50	NULL
ug/ml	NULL
*The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
BL	NULL
,	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
;	NULL
aa	NULL
,	NULL
amino	NULL
acids	NULL
;	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
;	NULL
wt	NULL
,	NULL
wild	NULL
type	NULL
.	NULL

24921	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
24922	NULL
gentamycin	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
.	NULL

Transient	NULL
Transfections	NULL
and	NULL
CAT	NULL
Assays-Cells	NULL
were	NULL
resuspended	NULL
in	NULL
fresh	NULL
medium	NULL
at	NULL
a	NULL
density	NULL
of	NULL
2	NULL
X	NULL
10°	NULL
cells/ml	NULL
24	NULL
h	NULL
prior	NULL
to	NULL
transfection	NULL
.	NULL

For	NULL
transfections	NULL
,	NULL
5	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
5-50	NULL
min	NULL
at	NULL
87	NULL
°C	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
transfection	NULL
medium	NULL
(	NULL
culture	NULL
medium	NULL
lacking	NULL
fetal	NULL
calf	NULL
serum	NULL
and	NULL
containing	NULL
50	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
)	NULL
,	NULL
containing	NULL
150-500	NULL
ug/ml	NULL
DEAE-Dextran	NULL
(	NULL
Pharmacia	NULL
Biotech	NULL
Inc.	NULL
,	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
and	NULL
15	NULL
ug	NULL
of	NULL
plasmid	NULL
DNA	NULL
(	NULL
8	NULL
ug	NULL
of	NULL
B-galactosidase	NULL
plasmid	NULL
pON405	NULL
as	NULL
standard	NULL
,	NULL
3	NULL
ug	NULL
of	NULL
CAT	NULL
reporter	NULL
plasmid	NULL
,	NULL
and	NULL
the	NULL
indicated	NULL
quantities	NULL
of	NULL
the	NULL
A-MYB	NULL
expression	NULL
plasmids	NULL
and/or	NULL
empty	NULL
expression	NULL
vector	NULL
)	NULL
.	NULL

The	NULL
transfection	NULL
conditions	NULL
were	NULL
optimized	NULL
for	NULL
each	NULL
cell	NULL
line	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
washed	NULL
and	NULL
cultured	NULL
in	NULL
8	NULL
ml	NULL
of	NULL
complete	NULL
medium	NULL
for	NULL
48	NULL
h.	NULL
The	NULL
harvested	NULL
cells	NULL
were	NULL
lysed	NULL
by	NULL
repeated	NULL
freezing	NULL
and	NULL
thawing	NULL
,	NULL
and	NULL
the	NULL
lysates	NULL
were	NULL
cleared	NULL
by	NULL
centrifugation	NULL
at	NULL
13,000	NULL
rpm	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
total	NULL
protein	NULL
,	NULL
determined	NULL
with	NULL
the	NULL
Bio-Rad	NULL
protein	NULL
assay	NULL
(	NULL
Bio-Rad	NULL
)	NULL
,	NULL
were	NULL
used	NULL
for	NULL
B-galactosidase	NULL
and	NULL
CAT	NULL
assays	NULL
.	NULL

CAT	NULL
assays	NULL
were	NULL
performed	NULL
using	NULL
a	NULL
phase-extraction	NULL
protocol	NULL
(	NULL
20	NULL
)	NULL
.	NULL

The	NULL
CAT	NULL
activity	NULL
values	NULL
were	NULL
normalized	NULL
to	NULL
the	NULL
B-galactosidase	NULL
activity	NULL
.	NULL

Plasmid	NULL
Constructions-The	NULL
KHK-CAT	NULL
plasmid	NULL
was	NULL
as	NULL
described	NULL
(	NULL
21	NULL
)	NULL
.	NULL

The	NULL
A-MYB	NULL
wt	NULL
,	NULL
pCAD1	NULL
,	NULL
pA1l	NULL
,	NULL
and	NULL
mutant	NULL
1	NULL
expression	NULL
constructs	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
19	NULL
)	NULL
and	NULL
are	NULL
all	NULL
subcloned	NULL
in	NULL
the	NULL
pSGS5	NULL
expression	NULL
vector	NULL
containing	NULL
the	NULL
SV40	NULL
promoter	NULL
(	NULL
Stratagene	NULL
)	NULL
.	NULL

The	NULL
MYC	NULL
promoter	NULL
CAT	NULL
construct	NULL
was	NULL
a	NULL
kind	NULL
gift	NULL
of	NULL
Dr.	NULL
L.	NULL
Lombardi	NULL
(	NULL
Institute	NULL
of	NULL
Medical	NULL
Sciences	NULL
,	NULL
Ospedale	NULL
Maggiore	NULL
,	NULL
Milan	NULL
,	NULL
Italy	NULL
)	NULL
and	NULL
contains	NULL
the	NULL
human	NULL
c-MYC	NULL
promoter	NULL
from	NULL
the	NULL
HindIII	NULL
site	NULL
2.5	NULL
kilobases	NULL
upstream	NULL
from	NULL
the	NULL
first	NULL
exon	NULL
of	NULL
c-MYC	NULL
,	NULL
to	NULL
the	NULL
Puull	NULL
site	NULL
at	NULL
the	NULL
end	NULL
of	NULL
the	NULL
first	NULL
exon	NULL
,	NULL
placed	NULL
upstream	NULL
from	NULL
the	NULL
CAT	NULL
gene	NULL
in	NULL
pSVOCAT	NULL
.	NULL

The	NULL
GAL4	NULL
reporter	NULL
construct	NULL
17MX2-Hc-CAT	NULL
contains	NULL
two	NULL
copies	NULL
of	NULL
the	NULL
GAL4	NULL
binding	NULL
site	NULL
cloned	NULL
upstream	NULL
from	NULL
the	NULL
CAT	NULL
gene	NULL
(	NULL
22	NULL
)	NULL
.	NULL

The	NULL
B-galactosidase	NULL
plasmid	NULL
pON405	NULL
contains	NULL
the	NULL
-galactosidase	NULL
cDNA	NULL
cloned	NULL
downstream	NULL
from	NULL
the	NULL
cytomegalovirus	NULL
promoter	NULL
.	NULL

pGA	NULL
was	NULL
generated	NULL
by	NULL
inserting	NULL
the	NULL
blunted	NULL
NdeI-EcoRV	NULL
fragment	NULL
from	NULL
A-MYB	NULL
mutant	NULL
1	NULL
(	NULL
17	NULL
)	NULL
in	NULL
the	NULL
blunted	NULL
ClaI	NULL
site	NULL
of	NULL
the	NULL
pG4M	NULL
poly	NULL
II	NULL
plasmid	NULL
carrying	NULL
part	NULL
of	NULL
the	NULL
GAL4	NULL
cDNA	NULL
(	NULL
23	NULL
)	NULL
.	NULL

The	NULL
construct	NULL
encodes	NULL
a	NULL
hybrid	NULL
protein	NULL
consisting	NULL
of	NULL
the	NULL
GAL4	NULL
DNA	NULL
binding	NULL
domain	NULL
from	NULL
aa	NULL
1	NULL
to	NULL
148	NULL
fused	NULL
in	NULL
frame	NULL
to	NULL
the	NULL
A-MYB	NULL
transactivation	NULL
domain	NULL
from	NULL
aa	NULL
218	NULL
to	NULL
318	NULL
.	NULL

The	NULL
Gal4	NULL
DNA	NULL
binding	NULL
domain	NULL
alone	NULL
(	NULL
pG-	NULL
)	NULL
was	NULL
encoded	NULL
by	NULL
the	NULL
pG4M	NULL
poly	NULL
II	NULL
plasmid	NULL
(	NULL
28	NULL
)	NULL
.	NULL

pAV	NULL
was	NULL
made	NULL
by	NULL
first	NULL
inserting	NULL
the	NULL
Xhol-XAol	NULL
fragment	NULL
from	NULL
the	NULL
plasmid	NULL
ER	NULL
(	NULL
C	NULL
)	NULL
-VP16	NULL
(	NULL
24	NULL
)	NULL
into	NULL
the	NULL
Ndel	NULL
site	NULL
of	NULL
the	NULL
A-MYB	NULL
cDNA	NULL
cloned	NULL
in	NULL
the	NULL
pECE	NULL
vector	NULL
and	NULL
then	NULL
transferring	NULL
the	NULL
complete	NULL
insert	NULL
into	NULL
the	NULL
BamHI	NULL
site	NULL
of	NULL
the	NULL
pSGS5	NULL
vector	NULL
(	NULL
Stratagene	NULL
)	NULL
,	NULL
resulting	NULL
in	NULL
a	NULL
hybrid	NULL
containing	NULL
the	NULL
A-MYB	NULL
DNA	NULL
binding	NULL
domain	NULL
(	NULL
aa	NULL
1-217	NULL
)	NULL
fused	NULL
in	NULL
frame	NULL
to	NULL
the	NULL
transactivation	NULL
domain	NULL
of	NULL
VP16	NULL
(	NULL
aa	NULL
411-490	NULL
)	NULL
.	NULL

The	NULL
pGV	NULL
control	NULL
plasmid	NULL
carried	NULL
the	NULL
same	NULL
XhoI	NULL
fragment	NULL
of	NULL
VP16	NULL
fused	NULL
in	NULL
frame	NULL
to	NULL
the	NULL
Gal4	NULL
DNA	NULL
binding	NULL
domain	NULL
encoding	NULL
aa	NULL
1-148	NULL
.	NULL

A	NULL
control	NULL
plasmid	NULL
carrying	NULL
only	NULL
the	NULL
complete	NULL
A-MYB	NULL
DNA	NULL
binding	NULL
domain	NULL
(	NULL
pA-	NULL
)	NULL
in	NULL
pSGS5	NULL
was	NULL
made	NULL
by	NULL
carboxy	NULL
truncation	NULL
at	NULL
a	NULL
mutated	NULL
BamHI	NULL
site	NULL
at	NULL
aa	NULL
position	NULL
262	NULL
(	NULL
17	NULL
)	NULL
.	NULL

The	NULL
pGST-A-MYB-DBD	NULL
construct	NULL
was	NULL
made	NULL
by	NULL
cloning	NULL
the	NULL
650-base	NULL
pair	NULL
NdeI	NULL
fragment	NULL
from	NULL
p1500	NULL
into	NULL
the	NULL
EcoRI	NULL
site	NULL
of	NULL
pGEX-3X	NULL
(	NULL
Pharmacia	NULL
)	NULL
.	NULL

This	NULL
construct	NULL
encodes	NULL
the	NULL
glutathione	NULL
trans-ferase	NULL
protein	NULL
in	NULL
frame	NULL
with	NULL
the	NULL
A-MYB	NULL
DNA	NULL
binding	NULL
domain	NULL
(	NULL
aa	NULL
2-217	NULL
)	NULL
.	NULL

All	NULL
constructions	NULL
were	NULL
verified	NULL
by	NULL
sequencing	NULL
.	NULL

Recombinant	NULL
Protein	NULL
Production	NULL
and	NULL
Purification-Bacteria	NULL
strain	NULL
K803	NULL
was	NULL
used	NULL
for	NULL
producing	NULL
the	NULL
GST	NULL
and	NULL
GST-A-MYB-DBD	NULL
fusion	NULL
proteins	NULL
.	NULL

After	NULL
induction	NULL
for	NULL
3	NULL
h	NULL
with	NULL
0.1	NULL
mM	NULL
isopropyl-B-D-thiogalacto-pyranoside	NULL
the	NULL
bacteria	NULL
were	NULL
harvested	NULL
and	NULL
resuspended	NULL
in	NULL
Solution	NULL
A	NULL
(	NULL
50	NULL
mm	NULL
HEPES	NULL
,	NULL
pH	NULL
8.0	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
5	NULL
mM	NULL
KCl	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
)	NULL
plus	NULL
0.1	NULL
mg/ml	NULL
lysozyme	NULL
and	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
10	NULL
min	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
treated	NULL
then	NULL
by	NULL
several	NULL
cycles	NULL
of	NULL
sonication	NULL
on	NULL
ice	NULL
,	NULL
and	NULL
the	NULL
lysates	NULL
containing	NULL
the	NULL
soluble	NULL
recombinant	NULL
protein	NULL
were	NULL
obtained	NULL
by	NULL
centrifugation	NULL
.	NULL

The	NULL
lysates	NULL
were	NULL
incubated	NULL
with	NULL
glutathione-agarose	NULL
beads	NULL
(	NULL
Sigma	NULL
)	NULL
for	NULL
1.5	NULL
h	NULL
at	NULL
4°C	NULL
,	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
Solution	NULL
A	NULL
,	NULL
and	NULL
either	NULL
eluted	NULL
with	NULL
glutathione	NULL
or	NULL
used	NULL
directly	NULL
for	NULL
protein	NULL
binding	NULL
assays	NULL
.	NULL

Metabolic	NULL
Labeling	NULL
and	NULL
Protein	NULL
Binding	NULL
Assay-10	NULL
X	NULL
10°	NULL
exponentially	NULL
growing	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
3	NULL
h	NULL
in	NULL
methionine-	NULL
and	NULL
cysteine-free	NULL
RPMI	NULL
medium	NULL
containing	NULL
200	NULL
Ci	NULL
of	NULL
pro-Mix	NULL
(	NULL
*°8	NULL
)	NULL
cell	NULL
labeling	NULL
mix	NULL
(	NULL
1000	NULL
Ci/mmol	NULL
,	NULL
Amersham	NULL
)	NULL
.	NULL

Labeled	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
200	NULL
ul	NULL
of	NULL
Buffer	NULL
1	NULL
(	NULL
20	NULL
mm	NULL
HEPES	NULL
,	NULL
pH	NULL
8.0	NULL
,	NULL
25	NULL
mM	NULL
KCl	NULL
,	NULL
5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
0.5	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
protease	NULL
inhibitors	NULL
)	NULL
and	NULL
centrifuged	NULL
at	NULL
1500	NULL
rpm	NULL
for	NULL
5	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

The	NULL
supernatant	NULL
contained	NULL
the	NULL
cytoplasmic	NULL
fraction	NULL
,	NULL
whereas	NULL
the	NULL
nuclear	NULL
pellet	NULL
was	NULL
further	NULL
extracted	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
in	NULL
100	NULL
l	NULL
of	NULL
Buffer	NULL
2	NULL
(	NULL
20	NULL
mm	NULL
HEPES	NULL
,	NULL
pH	NULL
8.0	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
5	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
0.5	NULL
M	NULL
NaCl	NULL
,	NULL
20	NULL
%	NULL
glycerol	NULL
,	NULL
protease	NULL
inhibitors	NULL
)	NULL
and	NULL
cleared	NULL
by	NULL
centrifugation	NULL
.	NULL

Both	NULL
cytoplasmic	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
diluted	NULL
1:4	NULL
in	NULL
Buffer	NULL
3	NULL
(	NULL
20	NULL
mm	NULL
HEPES	NULL
,	NULL
pH	NULL
8.0	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
5	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
20	NULL
%	NULL
glycerol	NULL
,	NULL
protease	NULL
inhibitors	NULL
)	NULL
and	NULL
incubated	NULL
with	NULL
20	NULL
ul	NULL
of	NULL
GST-bound	NULL
glutathione	NULL
agarose	NULL
for	NULL
1.5	NULL
h	NULL
at	NULL
4°C	NULL
and	NULL
centrifuged	NULL
.	NULL

These	NULL
precleared	NULL
extracts	NULL
B	NULL
Cell-specific	NULL
Activity	NULL
of	NULL
the	NULL
A-MYB	NULL
Transcription	NULL
Factor	NULL
DNA	NULL
binding	NULL
-	NULL
Transact	NULL
Inhibitory	NULL
CFIA	NULL
TAY	NULL
A	NULL
myb	NULL
wt	NULL
1	NULL
752	NULL
Urea	NULL
ae	NULL
eee	NULL
e	NULL
[	NULL
roe	NULL
n	NULL
e	NULL
i	NULL
ALL	NULL
iw	NULL
aI	NULL
)	NULL
A-myb	NULL
mutant	NULL
1	NULL
aa	NULL
e	NULL
pr	NULL
w	NULL
-	NULL
a	NULL
a	NULL
aa	NULL
)	NULL
:	NULL
pom	NULL
e	NULL
e	NULL
)	NULL
=	NULL
1	NULL
217	NULL
pA-1	NULL
262	NULL
A-myb	NULL
macaw/5:74	NULL
vP16	NULL
pAV	NULL
hybrid	NULL
1	NULL
217	NULL
A-myb	NULL
|	NULL
gata	NULL
_	NULL
[	NULL
RRM	NULL
]	NULL
-	NULL
pGA	NULL
hybrid	NULL
218	NULL
319	NULL
pGV	NULL
hybrid	NULL
pG-	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Schematic	NULL
representation	NULL
of	NULL
the	NULL
A-MYB	NULL
wt	NULL
,	NULL
mutant	NULL
,	NULL
and	NULL
hybrid	NULL
constructs	NULL
.	NULL

The	NULL
structure	NULL
of	NULL
the	NULL
wt	NULL
A-MYB	NULL
protein	NULL
is	NULL
indicated	NULL
on	NULL
fop	NULL
,	NULL
with	NULL
the	NULL
location	NULL
of	NULL
the	NULL
functional	NULL
domains	NULL
previously	NULL
defined	NULL
in	NULL
fibroblasts	NULL
.	NULL

The	NULL
three	NULL
arrows	NULL
in	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
refer	NULL
to	NULL
the	NULL
three	NULL
tandem	NULL
repeats	NULL
.	NULL

The	NULL
numbers	NULL
below	NULL
each	NULL
construct	NULL
indicate	NULL
the	NULL
first	NULL
and	NULL
last	NULL
amino	NULL
acid	NULL
of	NULL
the	NULL
A-MYB	NULL
fragments	NULL
present	NULL
in	NULL
each	NULL
protein	NULL
.	NULL

All	NULL
constructs	NULL
were	NULL
cloned	NULL
in	NULL
the	NULL
pSG5	NULL
expression	NULL
vector	NULL
.	NULL

were	NULL
further	NULL
incubated	NULL
1.5	NULL
h	NULL
at	NULL
4	NULL
°C	NULL
with	NULL
20	NULL
pl	NULL
of	NULL
GST-A-MYB-DBD-bound	NULL
glutathione	NULL
agarose	NULL
.	NULL

The	NULL
agarose	NULL
beads	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
Buffer	NULL
4	NULL
(	NULL
20	NULL
mm	NULL
HEPES	NULL
,	NULL
pH	NULL
8.0	NULL
,	NULL
1	NULL
mm	NULL
EDTA	NULL
,	NULL
5	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
100	NULL
mM	NULL
NaCl	NULL
,	NULL
0.02	NULL
%	NULL
Nonidet	NULL
P-40	NULL
)	NULL
,	NULL
analyzed	NULL
on	NULL
a	NULL
8	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
,	NULL
and	NULL
detected	NULL
by	NULL
autoradiography	NULL
.	NULL

RESULTS	NULL
A-MYB	NULL
Is	NULL
Active	NULL
in	NULL
B	NULL
Cells	NULL
but	NULL
Not	NULL
in	NULL
T	NULL
Cells-Previously	NULL
we	NULL
had	NULL
characterized	NULL
the	NULL
transcriptional	NULL
activity	NULL
and	NULL
several	NULL
functional	NULL
domains	NULL
of	NULL
the	NULL
A-MYB	NULL
protein	NULL
in	NULL
transfected	NULL
mouse	NULL
3T3	NULL
fibroblasts	NULL
(	NULL
17	NULL
,	NULL
19	NULL
)	NULL
.	NULL

Since	NULL
A-MYB	NULL
is	NULL
expressed	NULL
and	NULL
shows	NULL
biological	NULL
activity	NULL
in	NULL
vivo	NULL
during	NULL
a	NULL
narrow	NULL
stage	NULL
of	NULL
B	NULL
lymphoid	NULL
differentiation	NULL
and	NULL
not	NULL
in	NULL
other	NULL
hematopoietic	NULL
lineages	NULL
(	NULL
10	NULL
,	NULL
12	NULL
,	NULL
13	NULL
)	NULL
,	NULL
we	NULL
set	NULL
out	NULL
to	NULL
more	NULL
directly	NULL
investigate	NULL
the	NULL
transcriptional	NULL
activity	NULL
and	NULL
functional	NULL
domains	NULL
of	NULL
A-MYB	NULL
in	NULL
human	NULL
hematopoietic	NULL
cells	NULL
.	NULL

For	NULL
this	NULL
purpose	NULL
,	NULL
we	NULL
used	NULL
the	NULL
wt	NULL
A-MYB	NULL
cDNA	NULL
,	NULL
a	NULL
C-terminal	NULL
truncated	NULL
mutant	NULL
(	NULL
mutant	NULL
1	NULL
)	NULL
,	NULL
previously	NULL
shown	NULL
to	NULL
be	NULL
5-6-fold	NULL
more	NULL
active	NULL
than	NULL
the	NULL
wild	NULL
type	NULL
in	NULL
fibroblasts	NULL
(	NULL
17	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
two	NULL
mutants	NULL
carrying	NULL
deletions	NULL
of	NULL
the	NULL
previously	NULL
defined	NULL
DNA	NULL
binding	NULL
and	NULL
transactivation	NULL
domains	NULL
(	NULL
pCAD1L	NULL
and	NULL
pAl	NULL
,	NULL
respectively	NULL
)	NULL
(	NULL
19	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

All	NULL
constructs	NULL
were	NULL
cloned	NULL
in	NULL
the	NULL
pSGS	NULL
vector	NULL
carrying	NULL
the	NULL
SV40	NULL
promoter	NULL
and	NULL
expressed	NULL
comparable	NULL
levels	NULL
of	NULL
nuclear	NULL
A-MYB	NULL
protein	NULL
after	NULL
transfection	NULL
in	NULL
NIH-3T3	NULL
cells	NULL
(	NULL
17	NULL
,	NULL
19	NULL
)	NULL
.	NULL

The	NULL
transient	NULL
transfection	NULL
protocols	NULL
were	NULL
optimized	NULL
individually	NULL
for	NULL
each	NULL
of	NULL
a	NULL
number	NULL
of	NULL
hematopoietic	NULL
cell	NULL
lines	NULL
using	NULL
the	NULL
DEAE-Dextran	NULL
technique	NULL
.	NULL

Protocols	NULL
were	NULL
found	NULL
which	NULL
led	NULL
to	NULL
comparable	NULL
levels	NULL
of	NULL
transfection	NULL
efficiencies	NULL
in	NULL
different	NULL
human	NULL
T	NULL
and	NULL
B	NULL
cell	NULL
lines	NULL
,	NULL
as	NULL
measured	NULL
using	NULL
both	NULL
the	NULL
B-galactosidase	NULL
and	NULL
Rous	NULL
sarcoma	NULL
virus-CAT	NULL
reporters	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
and	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
the	NULL
maximal	NULL
transfection	NULL
efficiencies	NULL
obtained	NULL
with	NULL
several	NULL
myeloid	NULL
and	NULL
erythroid	NULL
cell	NULL
lines	NULL
were	NULL
at	NULL
least	NULL
10	NULL
times	NULL
lower	NULL
than	NULL
those	NULL
obtained	NULL
with	NULL
lymphoid	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Studies	NULL
on	NULL
the	NULL
A-MYB	NULL
activity	NULL
were	NULL
therefore	NULL
performed	NULL
only	NULL
with	NULL
the	NULL
more	NULL
efficient	NULL
lymphoid	NULL
cell	NULL
lines	NULL
.	NULL

Fig	NULL
.	NULL

2	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
shows	NULL
one	NULL
representative	NULL
dose	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
B	NULL
Cell-specific	NULL
Activity	NULL
of	NULL
the	NULL
A-MYB	NULL
Transcription	NULL
Factor	NULL
24923	NULL
TaBLE	NULL
I	NULL
Transcriptional	NULL
activity	NULL
of	NULL
A-MYB	NULL
and	NULL
mutants	NULL
in	NULL
different	NULL
cell	NULL
lines	NULL
Mean	NULL
transactivation	NULL
fold	NULL
(	NULL
S.D	NULL
.	NULL
)	NULL

*	NULL
Cell	NULL
line	NULL
Cell	NULL
type	NULL
A-myb	NULL
wt©	NULL
mutant	NULL
1	NULL
A-MYB	NULL
wt	NULL
mutant	NULL
1	NULL
pAV	NULL
pGA	NULL
¥	NULL
a	NULL
%	NULL
,	NULL
é§	NULL
}	NULL
}	NULL
%	NULL
$	NULL
'	NULL
(	NULL
l	NULL
‘	NULL
sl	NULL
’	NULL
.D	NULL
.	NULL
)	NULL

’	NULL
KHK-CAT	NULL
KHK-CAT	NULL
MYC-CAT	NULL
MYC-CAT	NULL
KHK-CAT	NULL
Gal4-CAT	NULL
Namalwa	NULL
B	NULL
(	NULL
BL	NULL
)	NULL
81	NULL
(	NULL
5	NULL
)	NULL
52	NULL
(	NULL
4	NULL
)	NULL
13	NULL
(	NULL
2	NULL
)	NULL
37	NULL
(	NULL
18	NULL
)	NULL
15	NULL
(	NULL
8	NULL
)	NULL
12	NULL
(	NULL
1	NULL
)	NULL
838	NULL
(	NULL
13	NULL
)	NULL
BJAB	NULL
B	NULL
(	NULL
NHL	NULL
)	NULL
1.3	NULL
(	NULL
0.2	NULL
)	NULL
21	NULL
(	NULL
1	NULL
)	NULL
ND	NULL
ND	NULL
ND	NULL
ND	NULL
59	NULL
(	NULL
8	NULL
)	NULL
IM-9	NULL
B	NULL
(	NULL
myeloma	NULL
)	NULL
1.6	NULL
(	NULL
0.3	NULL
)	NULL
20	NULL
(	NULL
1	NULL
)	NULL
ND	NULL
ND	NULL
ND	NULL
ND	NULL
48	NULL
(	NULL
8	NULL
)	NULL
EBV	NULL
B	NULL
(	NULL
EBV-LCL	NULL
)	NULL
0.8	NULL
(	NULL
0.1	NULL
)	NULL
19	NULL
(	NULL
8	NULL
)	NULL
ND	NULL
ND	NULL
ND	NULL
ND	NULL
10	NULL
(	NULL
4	NULL
)	NULL
Jurkat	NULL
T	NULL
(	NULL
T	NULL
leukemia	NULL
)	NULL
1.5	NULL
(	NULL
0.4	NULL
)	NULL
1.2	NULL
(	NULL
0.7	NULL
)	NULL
1	NULL
.	NULL

0	NULL
(	NULL
0.2	NULL
)	NULL
1.3	NULL
(	NULL
0.3	NULL
)	NULL
1.7	NULL
(	NULL
0.2	NULL
)	NULL
18	NULL
(	NULL
9	NULL
)	NULL
58	NULL
(	NULL
28	NULL
)	NULL
CEM	NULL
T	NULL
(	NULL
T-ALL	NULL
)	NULL
1.1	NULL
(	NULL
0.8	NULL
)	NULL
1.3	NULL
(	NULL
0.2	NULL
)	NULL
ND	NULL
ND	NULL
ND	NULL
ND	NULL
89	NULL
(	NULL
18	NULL
)	NULL
*	NULL
The	NULL
data	NULL
are	NULL
the	NULL
mean	NULL
and	NULL
S.D	NULL
.	NULL

(	NULL
values	NULL
in	NULL
parentheses	NULL
)	NULL
of	NULL
at	NULL
least	NULL
three	NULL
values	NULL
obtained	NULL
by	NULL
transfecting	NULL
9	NULL
ug	NULL
of	NULL
each	NULL
A-MYB	NULL
construct	NULL
.	NULL

Values	NULL
above	NULL
2	NULL
are	NULL
shown	NULL
in	NULL
bold	NULL
.	NULL

ND	NULL
,	NULL
not	NULL
determined	NULL
.	NULL

*	NULL
The	NULL
mean	NULL
percent	NULL
acylation	NULL
levels	NULL
and	NULL
S.D	NULL
.	NULL

(	NULL
values	NULL
in	NULL
parentheses	NULL
)	NULL
obtained	NULL
after	NULL
transfection	NULL
of	NULL
8	NULL
ug	NULL
of	NULL
RSV-CAT	NULL
plasmid	NULL
are	NULL
shown	NULL
.	NULL

°	NULL
The	NULL
A-MYB	NULL
construct	NULL
is	NULL
indicated	NULL
and	NULL
below	NULL
the	NULL
reporter	NULL
used	NULL
.	NULL

B	NULL
cell	NULL
lines	NULL
T	NULL
cell	NULL
lines	NULL
60	NULL
--	NULL
o-	NULL
_	NULL
NAMALWA	NULL
607	NULL
-	NULL
-	NULL
een	NULL
-A-	NULL
-	NULL
BJAB	NULL
3	NULL
50	NULL
ca-	NULL
-	NULL
me	NULL
so-	NULL
-S-	NULL
JURKAT	NULL
'-	NULL
ao	NULL
-a-	NULL
_	NULL
EBV	NULL
40	NULL
6	NULL
A-myb	NULL
§	NULL
30	NULL
80	NULL
-	NULL
wt	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Transcriptional	NULL
activity	NULL
of	NULL
5	NULL
20	NULL
»	NULL
o-|	NULL
A-MYB	NULL
wt	NULL
and	NULL
mutant	NULL
1	NULL
in	NULL
lymphoid	NULL
g	NULL
cell	NULL
lines	NULL
.	NULL

The	NULL
indicated	NULL
cell	NULL
lines	NULL
were	NULL
8	NULL
10	NULL
104	NULL
transiently	NULL
transfected	NULL
with	NULL
the	NULL
KHK-	NULL
-	NULL
o	NULL
a	NULL
a	NULL
-s	NULL
CAT	NULL
reporter	NULL
and	NULL
with	NULL
increasing	NULL
0	NULL
2	NULL
a	NULL
6	NULL
8s	NULL
10	NULL
-	NULL
0	NULL
2	NULL
q	NULL
6	NULL
s	NULL
'	NULL
amounts	NULL
of	NULL
either	NULL
wt	NULL
A-MYB	NULL
(	NULL
upper	NULL
pan-els	NULL
)	NULL
or	NULL
mutant	NULL
1	NULL
constructs	NULL
(	NULL
lower	NULL
panels	NULL
)	NULL
.	NULL

The	NULL
transcriptional	NULL
activity	NULL
was	NULL
meas-	NULL
eo	NULL
ured	NULL
.	NULL

after	NULL
normalization	NULL
for	NULL
transfection	NULL
3	NULL
-o-	NULL
efficiency	NULL
.	NULL

In	NULL
all	NULL
cases	NULL
,	NULL
percent	NULL
acylation	NULL
w.	NULL
--	NULL
O	NULL
--	NULL
-	NULL
NAMALWA	NULL
50	NULL
--	NULL
s-	NULL
-	NULL
CEM	NULL
was	NULL
below	NULL
90	NULL
%	NULL
.	NULL

The	NULL
data	NULL
are	NULL
representa-	NULL
5	NULL
A	NULL
BJAB	NULL
:	NULL
-	NULL
3	NULL
-o-	NULL
_	NULL
Mg	NULL
40	NULL
A-myb	NULL
tive	NULL
of	NULL
at	NULL
least	NULL
three	NULL
separate	NULL
experiments	NULL
.	NULL

8	NULL
-my	NULL
)	NULL
€	NULL
-a-	NULL
-	NULL
EBV	NULL
30	NULL
mutant	NULL
1	NULL
g	NULL
-	NULL
20	NULL
5	NULL
i-	NULL
10	NULL
10	NULL
of	NULL
T	NULL
T	NULL
T	NULL
=-2	NULL
4	NULL
6	NULL
8	NULL
10	NULL
0	NULL
2	NULL
4	NULL
6	NULL
8	NULL
Amount	NULL
of	NULL
Effector	NULL
Plasmid	NULL
(	NULL
ug	NULL
)	NULL
response	NULL
curve	NULL
of	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
A-MYB	NULL
wild	NULL
type	NULL
and	NULL
mutant	NULL
1	NULL
in	NULL
four	NULL
B	NULL
cell	NULL
lines	NULL
and	NULL
two	NULL
T	NULL
cell	NULL
lines	NULL
and	NULL
using	NULL
the	NULL
KHK-CAT	NULL
reporter	NULL
,	NULL
which	NULL
carries	NULL
eight	NULL
Myb	NULL
binding	NULL
sites	NULL
upstream	NULL
from	NULL
the	NULL
CAT	NULL
gene	NULL
.	NULL

Table	NULL
I	NULL
shows	NULL
the	NULL
mean	NULL
activity	NULL
and	NULL
standard	NULL
deviation	NULL
of	NULL
several	NULL
experiments	NULL
performed	NULL
with	NULL
the	NULL
highest	NULL
dose	NULL
of	NULL
each	NULL
construct	NULL
(	NULL
9	NULL
ug	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
a	NULL
measure	NULL
of	NULL
the	NULL
transfection	NULL
efficiencies	NULL
obtained	NULL
for	NULL
the	NULL
different	NULL
cell	NULL
lines	NULL
with	NULL
a	NULL
constant	NULL
amount	NULL
of	NULL
the	NULL
Rous	NULL
sarcoma	NULL
virus-CAT	NULL
plasmid	NULL
.	NULL

Out	NULL
of	NULL
six	NULL
different	NULL
lymphoid	NULL
cell	NULL
lines	NULL
tested	NULL
(	NULL
four	NULL
B	NULL
cell	NULL
and	NULL
two	NULL
T	NULL
cell	NULL
lines	NULL
)	NULL
,	NULL
wild	NULL
type	NULL
A-MYB	NULL
was	NULL
significantly	NULL
active	NULL
only	NULL
in	NULL
the	NULL
BL	NULL
cell	NULL
line	NULL
Namalwa	NULL
,	NULL
with	NULL
an	NULL
up	NULL
to	NULL
40-fold	NULL
induction	NULL
of	NULL
transcription	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
upper	NULL
panel	NULL
,	NULL
and	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

The	NULL
bell-shaped	NULL
curve	NULL
evaluable	NULL
in	NULL
the	NULL
dose-response	NULL
experiment	NULL
has	NULL
already	NULL
been	NULL
observed	NULL
in	NULL
3T3	NULL
cells	NULL
and	NULL
is	NULL
presumably	NULL
due	NULL
to	NULL
a	NULL
squelching	NULL
effect	NULL
(	NULL
18	NULL
,	NULL
19	NULL
)	NULL
.	NULL

The	NULL
C-terminally	NULL
truncated	NULL
mutant	NULL
1	NULL
,	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
reproduc-ibly	NULL
showed	NULL
transcriptional	NULL
activity	NULL
in	NULL
all	NULL
B	NULL
cell	NULL
lines	NULL
tested	NULL
,	NULL
with	NULL
a	NULL
19-21-fold	NULL
maximal	NULL
induction	NULL
in	NULL
most	NULL
cell	NULL
lines	NULL
and	NULL
a	NULL
stronger	NULL
activity	NULL
(	NULL
up	NULL
to	NULL
55-fold	NULL
)	NULL
in	NULL
Namalwa	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
lower	NULL
panel	NULL
,	NULL
and	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

On	NULL
the	NULL
contrary	NULL
,	NULL
mutant	NULL
1	NULL
,	NULL
like	NULL
wt	NULL
A-MYB	NULL
,	NULL
did	NULL
not	NULL
show	NULL
any	NULL
transcriptional	NULL
activity	NULL
in	NULL
the	NULL
two	NULL
T	NULL
cell	NULL
lines	NULL
tested	NULL
and	NULL
in	NULL
repeated	NULL
experiments	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
and	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

Thus	NULL
the	NULL
Namalwa	NULL
cell	NULL
line	NULL
(	NULL
a	NULL
BL	NULL
)	NULL
is	NULL
the	NULL
best	NULL
responder	NULL
for	NULL
A-MYB	NULL
activity	NULL
.	NULL

Mutant	NULL
1	NULL
is	NULL
more	NULL
active	NULL
than	NULL
wild	NULL
type	NULL
in	NULL
B	NULL
cells	NULL
as	NULL
previously	NULL
observed	NULL
in	NULL
NIH-3T3	NULL
fibroblasts	NULL
,	NULL
but	NULL
its	NULL
activity	NULL
is	NULL
cell	NULL
type-specific	NULL
,	NULL
being	NULL
detected	NULL
only	NULL
in	NULL
B	NULL
cell	NULL
lines	NULL
representative	NULL
of	NULL
different	NULL
stages	NULL
of	NULL
differentiation	NULL
(	NULL
BL	NULL
,	NULL
NHL	NULL
,	NULL
myeloma	NULL
,	NULL
and	NULL
EBV-LCL	NULL
)	NULL
but	NULL
not	NULL
in	NULL
the	NULL
two	NULL
T	NULL
cell	NULL
lines	NULL
studied	NULL
(	NULL
one	NULL
derived	NULL
from	NULL
an	NULL
acute	NULL
T-lymphoblastic	NULL
leukemia	NULL
Amount	NULL
of	NULL
Effector	NULL
Plasmid	NULL
(	NULL
ug	NULL
)	NULL
and	NULL
the	NULL
other	NULL
from	NULL
a	NULL
T	NULL
cell	NULL
leukemia	NULL
)	NULL
.	NULL

To	NULL
verify	NULL
whether	NULL
the	NULL
specificity	NULL
of	NULL
action	NULL
of	NULL
A-MYB	NULL
in	NULL
B	NULL
versus	NULL
T	NULL
cells	NULL
can	NULL
be	NULL
observed	NULL
also	NULL
when	NULL
using	NULL
a	NULL
normal	NULL
biologically	NULL
relevant	NULL
promoter	NULL
rather	NULL
than	NULL
an	NULL
artificial	NULL
construct	NULL
,	NULL
we	NULL
have	NULL
used	NULL
the	NULL
c-MYC	NULL
promoter	NULL
,	NULL
which	NULL
has	NULL
been	NULL
shown	NULL
previously	NULL
to	NULL
be	NULL
induced	NULL
by	NULL
A-MYB	NULL
(	NULL
14	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
and	NULL
Table	NULL
I	NULL
,	NULL
A-MYB	NULL
wt	NULL
can	NULL
also	NULL
activate	NULL
the	NULL
human	NULL
c-MYC	NULL
promoter	NULL
by	NULL
at	NULL
least	NULL
10-fold	NULL
in	NULL
Namalwa	NULL
cells	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
the	NULL
mutant	NULL
1	NULL
was	NULL
more	NULL
active	NULL
than	NULL
wild	NULL
type	NULL
on	NULL
the	NULL
MYC	NULL
promoter	NULL
in	NULL
the	NULL
same	NULL
cells	NULL
with	NULL
up	NULL
to	NULL
55-fold	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
and	NULL
Table	NULL
T	NULL
)	NULL
.	NULL

That	NULL
this	NULL
activity	NULL
was	NULL
dependent	NULL
on	NULL
both	NULL
the	NULL
DNA	NULL
binding	NULL
and	NULL
transactivation	NULL
domains	NULL
of	NULL
A-MYB	NULL
was	NULL
verified	NULL
using	NULL
the	NULL
pAl	NULL
and	NULL
pCAD1	NULL
constructs	NULL
,	NULL
which	NULL
completely	NULL
lost	NULL
activity	NULL
in	NULL
Namalwa	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
neither	NULL
the	NULL
wt	NULL
A-MYB	NULL
protein	NULL
nor	NULL
the	NULL
mutant	NULL
1	NULL
proteins	NULL
showed	NULL
any	NULL
activity	NULL
in	NULL
Jurkat	NULL
cells	NULL
using	NULL
the	NULL
c-MYC	NULL
promoter	NULL
construct	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
and	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
the	NULL
deletion	NULL
mutants	NULL
pAl	NULL
and	NULL
pCAD1	NULL
were	NULL
also	NULL
inactive	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Thus	NULL
we	NULL
conclude	NULL
that	NULL
i	NULL
)	NULL
A-MYB	NULL
is	NULL
able	NULL
to	NULL
activate	NULL
efficiently	NULL
the	NULL
c-MYC	NULL
promoter	NULL
in	NULL
a	NULL
B	NULL
cell	NULL
context	NULL
,	NULL
ii	NULL
)	NULL
the	NULL
A-MYB	NULL
functional	NULL
domains	NULL
previously	NULL
identified	NULL
in	NULL
fibroblasts	NULL
show	NULL
similar	NULL
functions	NULL
in	NULL
a	NULL
B	NULL
cell	NULL
context	NULL
and	NULL
using	NULL
a	NULL
natural	NULL
and	NULL
biologically	NULL
relevant	NULL
promoter	NULL
,	NULL
and	NULL
iii	NULL
)	NULL
A-MYB	NULL
is	NULL
completely	NULL
inactive	NULL
in	NULL
T	NULL
cells	NULL
even	NULL
when	NULL
using	NULL
such	NULL
promoter	NULL
.	NULL

The	NULL
A-MYB	NULL
DNA	NULL
Binding	NULL
Domain	NULL
Is	NULL
Responsible	NULL
for	NULL
Its	NULL
Specific	NULL
Activity	NULL
in	NULL
B	NULL
Cells-The	NULL
shortest	NULL
mutant	NULL
1	NULL
protein	NULL
contains	NULL
only	NULL
the	NULL
DNA	NULL
binding	NULL
and	NULL
transactivation	NULL
domains	NULL
of	NULL
A-MYB	NULL
(	NULL
aa	NULL
1-	NULL
319	NULL
,	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
and	NULL
shows	NULL
a	NULL
striking	NULL
difference	NULL
in	NULL
activity	NULL
in	NULL
T	NULL
cells	NULL
versus	NULL
B	NULL
cells	NULL
using	NULL
different	NULL
promoters	NULL
.	NULL

We	NULL
therefore	NULL
wanted	NULL
to	NULL
further	NULL
define	NULL
which	NULL
of	NULL
these	NULL
two	NULL
domains	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
24924	NULL
B	NULL
Cell-specific	NULL
Activity	NULL
of	NULL
the	NULL
A-MYB	NULL
Transcription	NULL
Factor	NULL
Namalwa	NULL
Jurkat	NULL
so-	NULL
|	NULL
-o-	NULL
_	NULL
Wild	NULL
Type	NULL
so-	NULL
,	NULL
|	NULL
-O-	NULL
Wild	NULL
Type	NULL
--	NULL
-	NULL
_-	NULL
Mutant	NULL
1	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Transcriptional	NULL
activity	NULL
of	NULL
A-MYB	NULL
wt	NULL
and	NULL
deletion	NULL
mutants	NULL
on	NULL
40	NULL
501	NULL
|	NULL
-o-	NULL
_	NULL
pM	NULL
-=-	NULL
_-	NULL
pCADi	NULL
-*-	NULL
-	NULL
Mutant	NULL
1	NULL
504	NULL
|	NULL
-o-	NULL
_	NULL
pA¥1	NULL
ad	NULL
-=-	NULL
_	NULL
pCAD1	NULL
the	NULL
MYC	NULL
promoter	NULL
.	NULL

The	NULL
indicated	NULL
cell	NULL
lines	NULL
were	NULL
transiently	NULL
transfected	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
but	NULL
using	NULL
the	NULL
human	NULL
MYC-CAT	NULL
construct	NULL
as	NULL
reporter	NULL
.	NULL

The	NULL
data	NULL
are	NULL
representative	NULL
of	NULL
at	NULL
least	NULL
three	NULL
separate	NULL
experiments	NULL
.	NULL

Transactivation	NULL
Fold	NULL
Amount	NULL
of	NULL
Effector	NULL
Plasmid	NULL
(	NULL
ug	NULL
)	NULL
Namalwa	NULL
Transactivation	NULL
Fold	NULL
2	NULL
4	NULL
6	NULL
8	NULL
10	NULL
Amount	NULL
of	NULL
Effector	NULL
Plasmid	NULL
(	NULL
ug	NULL
)	NULL
Jurkat	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

Transcriptional	NULL
activity	NULL
of	NULL
the	NULL
hybrid	NULL
constructs	NULL
in	NULL
Namalwa	NULL
and	NULL
Jurkat	NULL
cells	NULL
.	NULL

The	NULL
indicated	NULL
cell	NULL
lines	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
increasing	NULL
amounts	NULL
of	NULL
the	NULL
indicated	NULL
hybrid	NULL
and	NULL
control	NULL
constructs	NULL
and	NULL
3	NULL
ug	NULL
of	NULL
the	NULL
KHK-CAT	NULL
and	NULL
GAL4-CAT	NULL
reporters	NULL
,	NULL
as	NULL
appropriate	NULL
.	NULL

The	NULL
data	NULL
are	NULL
representative	NULL
of	NULL
at	NULL
least	NULL
three	NULL
separate	NULL
experiments	NULL
.	NULL

O	NULL
,	NULL
pAV	NULL
;	NULL
@	NULL
,	NULL
pGA	NULL
;	NULL
M	NULL
,	NULL
pGV	NULL
;	NULL
D	NULL
,	NULL
pG-	NULL
;	NULL
A	NULL
,	NULL
pA-	NULL
.	NULL

Amounts	NULL
of	NULL
Plasmid	NULL
(	NULL
ug	NULL
)	NULL
may	NULL
be	NULL
responsible	NULL
for	NULL
this	NULL
difference	NULL
in	NULL
activity	NULL
.	NULL

For	NULL
this	NULL
purpose	NULL
we	NULL
constructed	NULL
two	NULL
additional	NULL
mutants	NULL
,	NULL
one	NULL
(	NULL
pAV	NULL
)	NULL
containing	NULL
the	NULL
A-MYB	NULL
DNA	NULL
binding	NULL
domain	NULL
only	NULL
,	NULL
fused	NULL
in	NULL
frame	NULL
with	NULL
the	NULL
VP16	NULL
transactivation	NULL
domain	NULL
,	NULL
and	NULL
the	NULL
other	NULL
(	NULL
pGA	NULL
)	NULL
containing	NULL
the	NULL
GAL4	NULL
DNA	NULL
binding	NULL
domain	NULL
fused	NULL
in	NULL
frame	NULL
to	NULL
the	NULL
A-MYB	NULL
transactivation	NULL
domain	NULL
.	NULL

As	NULL
controls	NULL
,	NULL
we	NULL
also	NULL
used	NULL
a	NULL
hybrid	NULL
construct	NULL
(	NULL
pGV	NULL
)	NULL
carrying	NULL
the	NULL
Gal4	NULL
DNA	NULL
binding	NULL
domain	NULL
fused	NULL
to	NULL
the	NULL
VP16	NULL
transactivation	NULL
domain	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
DNA	NULL
binding	NULL
domains	NULL
alone	NULL
(	NULL
pG-	NULL
and	NULL
pA-	NULL
)	NULL
.	NULL

All	NULL
constructs	NULL
are	NULL
described	NULL
schematically	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

The	NULL
hybrids	NULL
were	NULL
tested	NULL
in	NULL
parallel	NULL
in	NULL
the	NULL
Namalwa	NULL
and	NULL
Jurkat	NULL
cell	NULL
lines	NULL
using	NULL
the	NULL
KHK-CAT	NULL
reporter	NULL
or	NULL
a	NULL
GAL4	NULL
reporter	NULL
,	NULL
as	NULL
appropriate	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
and	NULL
Table	NULL
I	NULL
,	NULL
all	NULL
constructs	NULL
carrying	NULL
both	NULL
a	NULL
DNA	NULL
binding	NULL
and	NULL
transactivation	NULL
domain	NULL
(	NULL
pAV	NULL
,	NULL
pGA	NULL
,	NULL
and	NULL
pGV	NULL
)	NULL
were	NULL
active	NULL
in	NULL
Namalwa	NULL
cells	NULL
(	NULL
in	NULL
a	NULL
dose-dependent	NULL
man-ner	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
only	NULL
the	NULL
pGA	NULL
and	NULL
pGV	NULL
hybrids	NULL
,	NULL
but	NULL
not	NULL
pAV	NULL
,	NULL
functioned	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
the	NULL
control	NULL
DNA	NULL
binding	NULL
domains	NULL
alone	NULL
(	NULL
pG-	NULL
and	NULL
pA-	NULL
)	NULL
were	NULL
inactive	NULL
in	NULL
both	NULL
cell	NULL
lines	NULL
against	NULL
their	NULL
respective	NULL
promoters	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Thus	NULL
both	NULL
the	NULL
A-MYB	NULL
and	NULL
VP16	NULL
transactivation	NULL
domains	NULL
are	NULL
functional	NULL
in	NULL
Jurkat	NULL
,	NULL
when	NULL
fused	NULL
to	NULL
the	NULL
GAL4	NULL
DNA	NULL
binding	NULL
domain	NULL
.	NULL

On	NULL
the	NULL
contrary	NULL
,	NULL
the	NULL
A-MYB	NULL
DNA	NULL
binding	NULL
domain	NULL
fused	NULL
to	NULL
the	NULL
strong	NULL
VP16	NULL
transactivation	NULL
domain	NULL
is	NULL
still	NULL
inactive	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
whereas	NULL
this	NULL
fusion	NULL
construct	NULL
is	NULL
active	NULL
in	NULL
Namalwa	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
and	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

The	NULL
A-MYB	NULL
DNA	NULL
Binding	NULL
Domain	NULL
Binds	NULL
a	NULL
110-kDa	NULL
Protein	NULL
Specifically	NULL
Present	NULL
in	NULL
B	NULL
Cells-The	NULL
above	NULL
data	NULL
suggested	NULL
that	NULL
either	NULL
a	NULL
co-activator	NULL
is	NULL
present	NULL
in	NULL
B	NULL
and	NULL
not	NULL
T	NULL
lymphoid	NULL
cells	NULL
or	NULL
that	NULL
an	NULL
inhibitor	NULL
is	NULL
present	NULL
in	NULL
T	NULL
and	NULL
not	NULL
B	NULL
lymphoid	NULL
cells	NULL
and	NULL
that	NULL
these	NULL
putative	NULL
co-activator	NULL
(	NULL
s	NULL
)	NULL
or	NULL
inhibitor	NULL
(	NULL
s	NULL
)	NULL
act	NULL
through	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
A-MYB	NULL
.	NULL

To	NULL
identify	NULL
such	NULL
putative	NULL
co-activator	NULL
or	NULL
inhibitor	NULL
,	NULL
we	NULL
subcloned	NULL
the	NULL
A-MYB	NULL
DNA	NULL
binding	NULL
domain	NULL
fused	NULL
in	NULL
frame	NULL
with	NULL
the	NULL
GST	NULL
protein	NULL
in	NULL
a	NULL
bacterial	NULL
expression	NULL
vector	NULL
.	NULL

Expression	NULL
of	NULL
this	NULL
construct	NULL
(	NULL
called	NULL
GST-A-	NULL
Amounts	NULL
of	NULL
Plasmid	NULL
(	NULL
ug	NULL
)	NULL
MYB-DBD	NULL
)	NULL
was	NULL
induced	NULL
in	NULL
bacteria	NULL
and	NULL
the	NULL
recombinant	NULL
protein	NULL
purified	NULL
on	NULL
a	NULL
glutathione	NULL
column	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

54	NULL
.	NULL

Finally	NULL
,	NULL
metabolically	NULL
labeled	NULL
lymphoid	NULL
cells	NULL
were	NULL
lysed	NULL
,	NULL
and	NULL
both	NULL
the	NULL
cytosolic	NULL
and	NULL
nuclear	NULL
lysates	NULL
were	NULL
passed	NULL
over	NULL
the	NULL
column	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
one	NULL
labeled	NULL
band	NULL
of	NULL
approximately	NULL
110	NULL
kDa	NULL
(	NULL
indicated	NULL
with	NULL
an	NULL
arrow	NULL
)	NULL
and	NULL
which	NULL
specifically	NULL
binds	NULL
the	NULL
A-MYB-DBD	NULL
is	NULL
observed	NULL
in	NULL
the	NULL
nuclear	NULL
lysates	NULL
of	NULL
all	NULL
B	NULL
cell	NULL
lines	NULL
tested	NULL
(	NULL
Namalwa	NULL
,	NULL
IM-9	NULL
,	NULL
and	NULL
EBV-LCL	NULL
cells	NULL
in	NULL
lanes	NULL
8	NULL
,	NULL
12	NULL
,	NULL
and	NULL
14	NULL
,	NULL
respectively	NULL
)	NULL
but	NULL
is	NULL
not	NULL
detected	NULL
in	NULL
the	NULL
two	NULL
T	NULL
cell	NULL
lines	NULL
(	NULL
Jurkat	NULL
and	NULL
CEM	NULL
,	NULL
lanes	NULL
7	NULL
and	NULL
10	NULL
)	NULL
.	NULL

The	NULL
110-kDa	NULL
B	NULL
cell	NULL
protein	NULL
is	NULL
mostly	NULL
nuclear	NULL
and	NULL
does	NULL
not	NULL
bind	NULL
to	NULL
GST	NULL
alone	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Several	NULL
other	NULL
bands	NULL
appear	NULL
to	NULL
specifically	NULL
bind	NULL
to	NULL
the	NULL
A-MYB	NULL
DNA	NULL
binding	NULL
domain	NULL
,	NULL
two	NULL
of	NULL
which	NULL
localize	NULL
to	NULL
the	NULL
cytoplasm	NULL
and	NULL
two	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

These	NULL
were	NULL
,	NULL
however	NULL
,	NULL
detected	NULL
in	NULL
all	NULL
lymphoid	NULL
extracts	NULL
tested	NULL
.	NULL

The	NULL
same	NULL
results	NULL
have	NULL
been	NULL
observed	NULL
in	NULL
at	NULL
least	NULL
three	NULL
separate	NULL
experiments	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
B	NULL
cells	NULL
contain	NULL
a	NULL
nuclear	NULL
protein	NULL
of	NULL
about	NULL
110	NULL
kDa	NULL
,	NULL
which	NULL
specifically	NULL
binds	NULL
to	NULL
the	NULL
A-MYB	NULL
DNA	NULL
binding	NULL
domain	NULL
,	NULL
but	NULL
is	NULL
not	NULL
present	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

This	NULL
protein	NULL
may	NULL
be	NULL
responsible	NULL
for	NULL
the	NULL
activity	NULL
of	NULL
A-MYB	NULL
in	NULL
B	NULL
versus	NULL
T	NULL
cells	NULL
.	NULL

DISCUSSION	NULL
In	NULL
this	NULL
report	NULL
we	NULL
show	NULL
that	NULL
the	NULL
A-MYB	NULL
transcription	NULL
factor	NULL
is	NULL
functionally	NULL
active	NULL
in	NULL
human	NULL
lymphoid	NULL
B	NULL
cell	NULL
but	NULL
not	NULL
in	NULL
T	NULL
cell	NULL
lines	NULL
.	NULL

The	NULL
functional	NULL
domains	NULL
previously	NULL
characterized	NULL
in	NULL
fibroblasts	NULL
(	NULL
17	NULL
,	NULL
19	NULL
)	NULL
,	NULL
in	NULL
particular	NULL
the	NULL
DNA	NULL
binding	NULL
,	NULL
transactivation	NULL
,	NULL
and	NULL
C-terminal	NULL
negative	NULL
regulatory	NULL
domains	NULL
,	NULL
appear	NULL
to	NULL
have	NULL
the	NULL
same	NULL
function	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
also	NULL
when	NULL
a	NULL
natural	NULL
promoter	NULL
such	NULL
as	NULL
the	NULL
c-MYC	NULL
promoter	NULL
is	NULL
used	NULL
as	NULL
a	NULL
reporter	NULL
.	NULL

We	NULL
show	NULL
that	NULL
the	NULL
region	NULL
responsible	NULL
for	NULL
the	NULL
specificity	NULL
of	NULL
activity	NULL
of	NULL
A-MYB	NULL
in	NULL
B	NULL
versus	NULL
T	NULL
cells	NULL
is	NULL
the	NULL
N-terminal	NULL
region	NULL
,	NULL
which	NULL
includes	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
.	NULL

Finally	NULL
,	NULL
in	NULL
an	NULL
attempt	NULL
to	NULL
characterize	NULL
the	NULL
molecular	NULL
reasons	NULL
for	NULL
this	NULL
cellular	NULL
specificity	NULL
,	NULL
we	NULL
have	NULL
identified	NULL
a	NULL
110-kDa	NULL
protein	NULL
present	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
all	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

A	NULL
nuclear	NULL
B	NULL
cell-specific	NULL
110-kDa	NULL
protein	NULL
binds	NULL
to	NULL
the	NULL
A-MYB	NULL
DNA	NULL
binding	NULL
domain	NULL
.	NULL

A	NULL
,	NULL
the	NULL
GST-A-MYB-DBD	NULL
protein	NULL
was	NULL
induced	NULL
with	NULL
isopropyl-B-D-thiogalactopyranoside	NULL
in	NULL
bacteria	NULL
and	NULL
purified	NULL
.	NULL

Total	NULL
cellular	NULL
lysates	NULL
from	NULL
unin-duced	NULL
(	NULL
Zane	NULL
1	NULL
)	NULL
and	NULL
induced	NULL
cells	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
were	NULL
analyzed	NULL
by	NULL
SDS-polyacrylamide	NULL
gel	NULL
B	NULL
electrophoresis	NULL
.	NULL

The	NULL
GST-A-MYB-DBD	NULL
[	NULL
fusion	NULL
protein	NULL
was	NULL
purified	NULL
on	NULL
glutathione-agarose	NULL
and	NULL
is	NULL
shown	NULL
in	NULL
lane	NULL
3	NULL
.	NULL

The	NULL
arrow	NULL
indicates	NULL
the	NULL
location	NULL
of	NULL
the	NULL
major	NULL
GST-A-MYB-DBD	NULL
product	NULL
before	NULL
and	NULL
after	NULL
purification	NULL
.	NULL

B	NULL
,	NULL
cells	NULL
metabolically	NULL
labeled	NULL
with	NULL
[	NULL
°°S	NULL
)	NULL
methionine	NULL
and	NULL
cysteine	NULL
were	NULL
lysed	NULL
and	NULL
the	NULL
cytoplasmic	NULL
or	NULL
nuclear	NULL
extracts	NULL
passed	NULL
over	NULL
purified	NULL
GST	NULL
alone	NULL
{	NULL
lanes	NULL
1-4	NULL
)	NULL
or	NULL
GST-A-MYB-DBD	NULL
bound	NULL
to	NULL
glutathione	NULL
beads	NULL
(	NULL
Zanes	NULL
5-14	NULL
)	NULL
.	NULL

After	NULL
washing	NULL
,	NULL
the	NULL
bound	NULL
proteins	NULL
were	NULL
analyzed	NULL
on	NULL
a	NULL
8	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
gel	NULL
and	NULL
-	NULL
autoradio-graphed	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
molecular	NULL
weight	NULL
markers	NULL
are	NULL
shown	NULL
on	NULL
the	NULL
right	NULL
.	NULL

B	NULL
Cell-specific	NULL
Activity	NULL
of	NULL
the	NULL
A-MYB	NULL
Transcription	NULL
Factor	NULL
24925	NULL
A	NULL
4	NULL
aos	NULL
wis	NULL
«	NULL
-	NULL
-	NULL
<	NULL
GST-A-myb	NULL
DBD	NULL
ast	NULL
;	NULL
GST-A-myb-DBD	NULL
£	NULL
&	NULL
#	NULL
&	NULL
ce	NULL
&	NULL
g	NULL
£	NULL
44	NULL
4	NULL
45	NULL
5	NULL
4	NULL
5	NULL
4	NULL
_F_¢	NULL
y	NULL
$	NULL
&	NULL
&	NULL
¢	NULL
¢	NULL
@	NULL
@	NULL
eranime	NULL
bakes	NULL
E	NULL
‘	NULL
—	NULL
es	NULL
fs	NULL
RE	NULL
a.	NULL
E-	NULL
_.	NULL
HB	NULL
Prot	NULL
``	NULL
oor	NULL
--	NULL
s	NULL
i	NULL
|-	NULL
66	NULL
kp	NULL
sane	NULL
<	NULL
in	NULL
.	NULL

meme	NULL
|-	NULL
45	NULL
kD	NULL
The	NULL
B	NULL
cell-specific	NULL
110-kDa	NULL
nuclear	NULL
pro	NULL
tein	NULL
is	NULL
indicated	NULL
by	NULL
an	NULL
arrow	NULL
.	NULL

4	NULL
2	NULL
four	NULL
B	NULL
cell	NULL
lines	NULL
tested	NULL
,	NULL
but	NULL
not	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
which	NULL
binds	NULL
specifically	NULL
to	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
A-MYB	NULL
.	NULL

We	NULL
suggest	NULL
that	NULL
this	NULL
110-kDa	NULL
protein	NULL
may	NULL
be	NULL
at	NULL
least	NULL
one	NULL
element	NULL
responsible	NULL
for	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
A-MYB	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Our	NULL
finding	NULL
that	NULL
A-MYB	NULL
is	NULL
active	NULL
in	NULL
B	NULL
,	NULL
but	NULL
not	NULL
T	NULL
,	NULL
cells	NULL
is	NULL
of	NULL
particular	NULL
interest	NULL
in	NULL
light	NULL
of	NULL
the	NULL
recent	NULL
report	NULL
using	NULL
A-MYB	NULL
transgenic	NULL
mice	NULL
and	NULL
showing	NULL
that	NULL
A-MYB	NULL
has	NULL
a	NULL
strong	NULL
and	NULL
specific	NULL
functional	NULL
effect	NULL
on	NULL
B	NULL
lymphocyte	NULL
proliferation	NULL
and/or	NULL
differentiation	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Although	NULL
these	NULL
mice	NULL
expressed	NULL
the	NULL
transgene	NULL
in	NULL
many	NULL
tissues	NULL
,	NULL
abnormalities	NULL
were	NULL
confined	NULL
primarily	NULL
to	NULL
B	NULL
lymphocytes	NULL
.	NULL

Hyperplasia	NULL
of	NULL
spleen	NULL
and	NULL
lymph	NULL
nodes	NULL
were	NULL
mostly	NULL
due	NULL
to	NULL
an	NULL
expanded	NULL
B	NULL
cell	NULL
population	NULL
showing	NULL
a	NULL
germinal	NULL
center	NULL
phenotype	NULL
(	NULL
13	NULL
)	NULL
.	NULL

These	NULL
data	NULL
are	NULL
in	NULL
line	NULL
with	NULL
previous	NULL
work	NULL
showing	NULL
that	NULL
,	NULL
among	NULL
hematopoietic	NULL
cells	NULL
,	NULL
expression	NULL
of	NULL
the	NULL
endogenous	NULL
A-MYB	NULL
gene	NULL
is	NULL
restricted	NULL
to	NULL
the	NULL
activated	NULL
B	NULL
cells	NULL
present	NULL
in	NULL
germinal	NULL
centers	NULL
(	NULL
10	NULL
,	NULL
11	NULL
)	NULL
.	NULL

Furthermore	NULL
A-MYB	NULL
expression	NULL
is	NULL
also	NULL
restricted	NULL
in	NULL
B	NULL
cell	NULL
neoplasms	NULL
,	NULL
being	NULL
found	NULL
only	NULL
in	NULL
BL	NULL
and	NULL
some	NULL
chronic	NULL
lymphocytic	NULL
leukemias	NULL
(	NULL
12	NULL
)	NULL
.	NULL

These	NULL
data	NULL
,	NULL
together	NULL
,	NULL
show	NULL
that	NULL
A-MYB	NULL
plays	NULL
an	NULL
important	NULL
functional	NULL
role	NULL
during	NULL
activation	NULL
and/or	NULL
differentiation	NULL
of	NULL
mature	NULL
B	NULL
lymphocytes	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
the	NULL
Myb	NULL
family	NULL
of	NULL
genes	NULL
has	NULL
nearly	NULL
always	NULL
been	NULL
studied	NULL
in	NULL
fibroblasts	NULL
or	NULL
epithelial	NULL
cells	NULL
which	NULL
are	NULL
most	NULL
easily	NULL
transfected	NULL
for	NULL
transient	NULL
assays	NULL
(	NULL
reviewed	NULL
in	NULL
Refs	NULL
.	NULL

3	NULL
and	NULL
25	NULL
)	NULL
.	NULL

The	NULL
only	NULL
other	NULL
cell	NULL
type	NULL
that	NULL
has	NULL
been	NULL
used	NULL
to	NULL
study	NULL
Myb	NULL
transcriptional	NULL
activity	NULL
is	NULL
the	NULL
chicken	NULL
macrophage	NULL
line	NULL
HD11	NULL
(	NULL
11	NULL
,	NULL
26	NULL
)	NULL
.	NULL

Thus	NULL
this	NULL
is	NULL
the	NULL
first	NULL
report	NULL
of	NULL
the	NULL
study	NULL
of	NULL
the	NULL
activity	NULL
of	NULL
a	NULL
Myb	NULL
transcription	NULL
factor	NULL
in	NULL
human	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Our	NULL
data	NULL
show	NULL
that	NULL
A-MYB	NULL
is	NULL
transcriptionally	NULL
active	NULL
in	NULL
all	NULL
B	NULL
cell	NULL
lines	NULL
studied	NULL
and	NULL
not	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
cellular	NULL
specificity	NULL
of	NULL
A-MYB	NULL
transcriptional	NULL
activity	NULL
in	NULL
B	NULL
versus	NULL
T	NULL
cells	NULL
is	NULL
of	NULL
particular	NULL
interest	NULL
.	NULL

We	NULL
believe	NULL
that	NULL
the	NULL
difference	NULL
reflected	NULL
a	NULL
true	NULL
biological	NULL
property	NULL
of	NULL
A-MYB	NULL
,	NULL
since	NULL
it	NULL
was	NULL
observed	NULL
in	NULL
all	NULL
the	NULL
lymphoid	NULL
cell	NULL
lines	NULL
tested	NULL
,	NULL
all	NULL
of	NULL
which	NULL
showed	NULL
comparable	NULL
transfection	NULL
efficiencies	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
the	NULL
A-MYB	NULL
wt	NULL
was	NULL
detectable	NULL
only	NULL
in	NULL
Namalwa	NULL
cells	NULL
,	NULL
which	NULL
were	NULL
the	NULL
best	NULL
responder	NULL
cell	NULL
line	NULL
also	NULL
for	NULL
the	NULL
stronger	NULL
mutant	NULL
1	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
Namalwa	NULL
cell	NULL
line	NULL
is	NULL
derived	NULL
from	NULL
a	NULL
BL	NULL
patient	NULL
and	NULL
A-MYB	NULL
is	NULL
highly	NULL
expressed	NULL
in	NULL
most	NULL
BL	NULL
cell	NULL
lines	NULL
,	NULL
although	NULL
the	NULL
Namalwa	NULL
line	NULL
itself	NULL
does	NULL
not	NULL
express	NULL
significant	NULL
endogenous	NULL
A-MYB	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Furthermore	NULL
the	NULL
phenotype	NULL
of	NULL
BL	NULL
cells	NULL
corresponds	NULL
to	NULL
that	NULL
of	NULL
normal	NULL
germinal	NULL
center	NULL
B	NULL
cells	NULL
,	NULL
which	NULL
are	NULL
the	NULL
cells	NULL
that	NULL
accumulate	NULL
in	NULL
the	NULL
A-MYB	NULL
transgenic	NULL
animals	NULL
.	NULL

Activity	NULL
of	NULL
the	NULL
stronger	NULL
mutant	NULL
1	NULL
could	NULL
be	NULL
detected	NULL
in	NULL
all	NULL
B	NULL
cell	NULL
lines	NULL
,	NULL
but	NULL
not	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

This	NULL
difference	NULL
could	NULL
not	NULL
be	NULL
due	NULL
to	NULL
the	NULL
levels	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
endogenous	NULL
MYB	NULL
genes	NULL
since	NULL
we	NULL
found	NULL
no	NULL
correlation	NULL
between	NULL
A-MYB	NULL
activity	NULL
and	NULL
levels	NULL
of	NULL
A-MYB	NULL
,	NULL
B-MYB	NULL
,	NULL
or	NULL
c-MYB	NULL
mRNA	NULL
or	NULL
protein	NULL
in	NULL
the	NULL
same	NULL
cell	NULL
lines	NULL
(	NULL
12	NULL
)	NULL
.	NULL
``	NULL

For	NULL
this	NULL
reason	NULL
,	NULL
we	NULL
have	NULL
started	NULL
a	NULL
molecular	NULL
characterization	NULL
of	NULL
the	NULL
tissue	NULL
specificity	NULL
of	NULL
the	NULL
A-MYB	NULL
gene	NULL
.	NULL

In	NULL
this	NULL
report	NULL
we	NULL
show	NULL
that	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
first	NULL
217	NULL
N-terminal	NULL
amino	NULL
acids	NULL
that	NULL
contains	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
is	NULL
sufficient	NULL
to	NULL
give	NULL
B	NULL
cell-specific	NULL
activity	NULL
when	NULL
fused	NULL
to	NULL
the	NULL
VP16	NULL
transactivation	NULL
domain	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
the	NULL
A-MYB	NULL
transactivation	NULL
domain	NULL
(	NULL
aa	NULL
218-318	NULL
)	NULL
is	NULL
functional	NULL
in	NULL
both	NULL
T	NULL
and	NULL
B	NULL
cells	NULL
when	NULL
fused	NULL
to	NULL
the	NULL
GAL4	NULL
DNA	NULL
binding	NULL
domain	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
show	NULL
in	NULL
binding	NULL
assays	NULL
using	NULL
bacterially	NULL
produced	NULL
GST-A-MYB	NULL
that	NULL
all	NULL
B	NULL
cell	NULL
lines	NULL
tested	NULL
,	NULL
but	NULL
not	NULL
T	NULL
cells	NULL
,	NULL
contain	NULL
a	NULL
nuclear	NULL
protein	NULL
of	NULL
about	NULL
110	NULL
kDa	NULL
,	NULL
which	NULL
specifically	NULL
binds	NULL
to	NULL
the	NULL
A-MYB	NULL
DNA	NULL
binding	NULL
domain	NULL
.	NULL

On	NULL
the	NULL
basis	NULL
of	NULL
these	NULL
results	NULL
we	NULL
hypothesize	NULL
that	NULL
this	NULL
110-kDa	NULL
nuclear	NULL
protein	NULL
found	NULL
in	NULL
B	NULL
cells	NULL
is	NULL
a	NULL
co-activator	NULL
of	NULL
A-MYB	NULL
function	NULL
.	NULL

We	NULL
do	NULL
not	NULL
know	NULL
the	NULL
molecular	NULL
basis	NULL
for	NULL
the	NULL
higher	NULL
A-MYB	NULL
activity	NULL
in	NULL
Namalwa	NULL
relative	NULL
to	NULL
other	NULL
B	NULL
cells	NULL
,	NULL
since	NULL
equivalent	NULL
amounts	NULL
of	NULL
p110	NULL
were	NULL
detected	NULL
in	NULL
all	NULL
B	NULL
cell	NULL
lines	NULL
;	NULL
thus	NULL
this	NULL
difference	NULL
may	NULL
depend	NULL
on	NULL
other	NULL
factors	NULL
binding	NULL
to	NULL
A-MYB	NULL
(	NULL
17	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
p110	NULL
may	NULL
be	NULL
responsible	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
for	NULL
the	NULL
specific	NULL
functional	NULL
effects	NULL
of	NULL
the	NULL
A-MYB	NULL
transgene	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

The	NULL
confirmation	NULL
of	NULL
such	NULL
hypotheses	NULL
will	NULL
require	NULL
the	NULL
cloning	NULL
of	NULL
this	NULL
110-kDa	NULL
protein	NULL
,	NULL
which	NULL
is	NULL
under	NULL
way	NULL
and	NULL
is	NULL
beyond	NULL
the	NULL
scope	NULL
of	NULL
this	NULL
paper	NULL
.	NULL

Recently	NULL
a	NULL
100-kDa	NULL
protein	NULL
called	NULL
p100	NULL
has	NULL
been	NULL
described	NULL
that	NULL
binds	NULL
to	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
c-MYB	NULL
(	NULL
27	NULL
)	NULL
.	NULL

We	NULL
have	NULL
evidence	NULL
that	NULL
our	NULL
110-kDa	NULL
protein	NULL
is	NULL
not	NULL
p100	NULL
,	NULL
since	NULL
p110	NULL
did	NULL
not	NULL
react	NULL
in	NULL
Western	NULL
blots	NULL
with	NULL
an	NULL
anti-p100	NULL
antiserum	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
E.	NULL
Kieff	NULL
,	NULL
Harvard	NULL
University	NULL
,	NULL
Boston	NULL
)	NULL
.	NULL
``	NULL

Furthermore	NULL
p100	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
ubiquitous	NULL
(	NULL
27	NULL
,	NULL
28	NULL
)	NULL
,	NULL
and	NULL
its	NULL
role	NULL
in	NULL
regulating	NULL
c-MYB	NULL
transcriptional	NULL
activity	NULL
is	NULL
unclear	NULL
at	NULL
present	NULL
(	NULL
27	NULL
)	NULL
.	NULL

It	NULL
is	NULL
intriguing	NULL
that	NULL
the	NULL
domain	NULL
responsible	NULL
for	NULL
cell	NULL
type-specific	NULL
activity	NULL
is	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
.	NULL

We	NULL
do	NULL
not	NULL
know	NULL
whether	NULL
the	NULL
lack	NULL
of	NULL
transactivation	NULL
activity	NULL
of	NULL
A-MYB	NULL
in	NULL
T	NULL
cells	NULL
reflects	NULL
lack	NULL
of	NULL
DNA	NULL
binding	NULL
.	NULL

The	NULL
transfection	NULL
efficiency	NULL
was	NULL
too	NULL
low	NULL
in	NULL
either	NULL
T	NULL
or	NULL
B	NULL
cells	NULL
to	NULL
measure	NULL
DNA	NULL
binding	NULL
activity	NULL
directly	NULL
.	NULL

We	NULL
therefore	NULL
investigated	NULL
whether	NULL
preincubation	NULL
of	NULL
*	NULL
G.-G.	NULL
Ying	NULL
,	NULL
unpublished	NULL
data	NULL
.	NULL

610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
24926	NULL
A-MYB-transfected	NULL
3T3	NULL
fibroblast	NULL
extracts	NULL
with	NULL
either	NULL
T	NULL
or	NULL
B	NULL
cell	NULL
nuclear	NULL
extracts	NULL
affected	NULL
A-MYB	NULL
DNA	NULL
binding	NULL
.	NULL

We	NULL
did	NULL
not	NULL
observe	NULL
any	NULL
measurable	NULL
effect	NULL
of	NULL
the	NULL
extracts	NULL
on	NULL
binding	NULL
.	NULL
``	NULL

A	NULL
more	NULL
detailed	NULL
understanding	NULL
of	NULL
the	NULL
mechanism	NULL
of	NULL
regulation	NULL
of	NULL
A-MYB	NULL
activity	NULL
will	NULL
therefore	NULL
require	NULL
cloning	NULL
of	NULL
the	NULL
putative	NULL
co-factors	NULL
such	NULL
as	NULL
p110	NULL
involved	NULL
in	NULL
this	NULL
regulation	NULL
.	NULL

This	NULL
report	NULL
also	NULL
shows	NULL
that	NULL
the	NULL
functional	NULL
domains	NULL
of	NULL
A-MYB	NULL
previously	NULL
characterized	NULL
in	NULL
fibroblasts	NULL
have	NULL
the	NULL
same	NULL
properties	NULL
in	NULL
B	NULL
cells	NULL
(	NULL
17	NULL
)	NULL
.	NULL

In	NULL
particular	NULL
the	NULL
transactivation	NULL
domain	NULL
of	NULL
A-MYB	NULL
has	NULL
been	NULL
shown	NULL
here	NULL
to	NULL
be	NULL
functional	NULL
also	NULL
when	NULL
fused	NULL
to	NULL
a	NULL
heterologous	NULL
DNA	NULL
binding	NULL
domain	NULL
(	NULL
from	NULL
GAL4	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
the	NULL
C-terminal	NULL
half	NULL
of	NULL
the	NULL
protein	NULL
shows	NULL
strong	NULL
inhibitory	NULL
activity	NULL
,	NULL
reducing	NULL
transactivation	NULL
by	NULL
2-3-fold	NULL
in	NULL
a	NULL
similar	NULL
manner	NULL
to	NULL
what	NULL
had	NULL
been	NULL
observed	NULL
in	NULL
NIH-3T3	NULL
cells	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Furthermore	NULL
we	NULL
show	NULL
here	NULL
that	NULL
this	NULL
effect	NULL
is	NULL
apparent	NULL
also	NULL
when	NULL
a	NULL
natural	NULL
and	NULL
biologically	NULL
relevant	NULL
promoter	NULL
is	NULL
being	NULL
used	NULL
as	NULL
a	NULL
reporter	NULL
,	NULL
the	NULL
human	NULL
c-MYC	NULL
promoter	NULL
.	NULL

Previously	NULL
the	NULL
murine	NULL
c-MYC	NULL
promoter	NULL
had	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
regulated	NULL
by	NULL
A-MYB	NULL
in	NULL
smooth	NULL
muscle	NULL
cells	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Interestingly	NULL
the	NULL
c-MYC	NULL
gene	NULL
is	NULL
expressed	NULL
in	NULL
the	NULL
centroblasts	NULL
of	NULL
germinal	NULL
center	NULL
,	NULL
like	NULL
A-MYB	NULL
(	NULL
29	NULL
)	NULL
,	NULL
and	NULL
more	NULL
importantly	NULL
is	NULL
the	NULL
target	NULL
of	NULL
chromosomal	NULL
transloca-tions	NULL
in	NULL
100	NULL
%	NULL
Burkitt	NULL
's	NULL
lymphomas	NULL
;	NULL
for	NULL
this	NULL
reason	NULL
it	NULL
is	NULL
considered	NULL
as	NULL
a	NULL
crucial	NULL
element	NULL
in	NULL
the	NULL
transformation	NULL
of	NULL
such	NULL
tumors	NULL
(	NULL
30	NULL
)	NULL
.	NULL

One	NULL
possible	NULL
speculation	NULL
is	NULL
that	NULL
A-MYB	NULL
and	NULL
c-MYC	NULL
may	NULL
amplifiy	NULL
each	NULL
other	NULL
and	NULL
cooperate	NULL
in	NULL
the	NULL
oncogenic	NULL
effect	NULL
(	NULL
14	NULL
)	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
the	NULL
A-MYB	NULL
transcription	NULL
factor	NULL
is	NULL
expressed	NULL
and	NULL
is	NULL
functional	NULL
during	NULL
a	NULL
narrow	NULL
stage	NULL
of	NULL
B	NULL
cell	NULL
lymphoid	NULL
differentiation	NULL
and	NULL
may	NULL
function	NULL
in	NULL
this	NULL
context	NULL
by	NULL
cooperating	NULL
with	NULL
B	NULL
cell-specific	NULL
co-factors	NULL
.	NULL

This	NULL
information	NULL
is	NULL
reminiscent	NULL
of	NULL
what	NULL
has	NULL
been	NULL
previously	NULL
observed	NULL
for	NULL
other	NULL
transcription	NULL
factors	NULL
,	NULL
which	NULL
can	NULL
acquire	NULL
B	NULL
cell	NULL
specificity	NULL
through	NULL
interaction	NULL
with	NULL
co-factors	NULL
(	NULL
31-33	NULL
)	NULL
,	NULL
and	NULL
supports	NULL
the	NULL
notion	NULL
that	NULL
A-MYB	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
B	NULL
cell	NULL
differentiation	NULL
process	NULL
itself	NULL
.	NULL

Acknowledgment-We	NULL
thank	NULL
Dr.	NULL
E.	NULL
Kieff	NULL
(	NULL
Department	NULL
of	NULL
Microbiology	NULL
and	NULL
Molecular	NULL
Genetics	NULL
,	NULL
Harvard	NULL
University	NULL
,	NULL
Boston	NULL
)	NULL
for	NULL
having	NULL
kindly	NULL
provided	NULL
us	NULL
with	NULL
anti-p100	NULL
antiserum	NULL
and	NULL
p100	NULL
eDNA	NULL
construct	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Rabbits	NULL
,	NULL
T.	NULL
H.	NULL
(	NULL
1994	NULL
)	NULL
Nature	NULL
872	NULL
,	NULL
148-149	NULL
2	NULL
.	NULL

Nomura	NULL
,	NULL
N.	NULL
,	NULL
Takahashi	NULL
,	NULL
M.	NULL
,	NULL
Matsui	NULL
,	NULL
M.	NULL
,	NULL
Ishii	NULL
,	NULL
S.	NULL
,	NULL
Date	NULL
,	NULL
T.	NULL
,	NULL
Sasamoto	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
0	NULL
Quim	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

28.	NULL
.	NULL

Tora	NULL
,	NULL
L.	NULL
,	NULL
White	NULL
,	NULL
J.	NULL
,	NULL
Brou	NULL
,	NULL
C.	NULL
,	NULL
Tasset	NULL
,	NULL
D.	NULL
,	NULL
Webster	NULL
,	NULL
N.	NULL
,	NULL
Scheer	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Chambon	NULL
,	NULL
25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

B	NULL
Cell-specific	NULL
Activity	NULL
of	NULL
the	NULL
A-MYB	NULL
Transcription	NULL
Factor	NULL
Ishizaki	NULL
,	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

16	NULL
,	NULL
11075-11089	NULL
.	NULL

Introna	NULL
,	NULL
M.	NULL
,	NULL
Luchetti	NULL
,	NULL
M.	NULL
,	NULL
Castellano	NULL
,	NULL
M.	NULL
,	NULL
Arsura	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Golay	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Semin	NULL
.	NULL

Cancer	NULL
Biol	NULL
.	NULL

5	NULL
,	NULL
113-124	NULL
.	NULL

Lipsick	NULL
,	NULL
J.	NULL
S.	NULL
(	NULL
1996	NULL
)	NULL
Oncogene	NULL
18	NULL
,	NULL
228-285	NULL
.	NULL

Graf	NULL
,	NULL
T.	NULL
(	NULL
1992	NULL
)	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Genet	NULL
.	NULL

Dev	NULL
.	NULL

2	NULL
,	NULL
249-255	NULL
.	NULL

Mucenski	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
Mclain	NULL
,	NULL
K.	NULL
,	NULL
Kier	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
,	NULL
Swerdlow	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
Schreiner	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Miller	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
Pietryga	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Scott	NULL
,	NULL
W.	NULL
J.	NULL
J.	NULL
,	NULL
and	NULL
Potter	NULL
,	NULL
S.	NULL
S.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
65	NULL
,	NULL
677-689	NULL
.	NULL

Arsura	NULL
,	NULL
M.	NULL
,	NULL
Introna	NULL
,	NULL
M.	NULL
,	NULL
Passerini	NULL
,	NULL
F.	NULL
,	NULL
Mantovani	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Golay	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Blood	NULL
79	NULL
,	NULL
2708-2716	NULL
.	NULL

Reiss	NULL
,	NULL
K.	NULL
,	NULL
Travali	NULL
,	NULL
S.	NULL
,	NULL
Calabretta	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Baserga	NULL
,	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
.	NULL

Physiol	NULL
.	NULL

148	NULL
,	NULL
338-348	NULL
.	NULL

Lin	NULL
,	NULL
D.	NULL
,	NULL
Fiscella	NULL
,	NULL
M.	NULL
,	NULL
O'Connor	NULL
,	NULL
P.	NULL
M.	NULL
,	NULL
Jackman	NULL
,	NULL
J.	NULL
,	NULL
Chen	NULL
,	NULL
M.	NULL
,	NULL
Luo	NULL
,	NULL
L.	NULL
L.	NULL
,	NULL
Sala	NULL
,	NULL
A.	NULL
,	NULL
Travali	NULL
,	NULL
S.	NULL
,	NULL
Appella	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Mercer	NULL
,	NULL
W.	NULL
E.	NULL
(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

91	NULL
,	NULL
10079-10083	NULL
Golay	NULL
,	NULL
J.	NULL
,	NULL
Erba	NULL
,	NULL
E.	NULL
,	NULL
Bernasconi	NULL
,	NULL
S.	NULL
,	NULL
Peri	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Introna	NULL
,	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

158	NULL
,	NULL
548-558	NULL
Trauth	NULL
,	NULL
K.	NULL
,	NULL
Mutschler	NULL
,	NULL
B.	NULL
,	NULL
Jenkins	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
Gilbert	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Copeland	NULL
,	NULL
N.	NULL
G.	NULL
,	NULL
and	NULL
Klempnauer	NULL
,	NULL
K.	NULL
H.	NULL
(	NULL
1994	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

18	NULL
,	NULL
5994-6005	NULL
Golay	NULL
,	NULL
J.	NULL
,	NULL
Luppi	NULL
,	NULL
M.	NULL
,	NULL
Songia	NULL
,	NULL
S.	NULL
,	NULL
Palvarini	NULL
,	NULL
C.	NULL
,	NULL
Lombardi	NULL
,	NULL
L.	NULL
,	NULL
Aiello	NULL
,	NULL
A.	NULL
,	NULL
Delia	NULL
,	NULL
D.	NULL
,	NULL
Lam	NULL
,	NULL
K.	NULL
,	NULL
Crawford	NULL
,	NULL
D.	NULL
H.	NULL
,	NULL
Biondi	NULL
,	NULL
A.	NULL
,	NULL
Barbui	NULL
,	NULL
T.	NULL
,	NULL
Rambaldi	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Introna	NULL
,	NULL
M.	NULL
(	NULL
1996	NULL
)	NULL
Blood	NULL
87	NULL
,	NULL
1900-1911	NULL
DeRocco	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
lozzo	NULL
,	NULL
R.	NULL
,	NULL
Ma	NULL
,	NULL
X.	NULL
P.	NULL
,	NULL
Schwarting	NULL
,	NULL
R.	NULL
,	NULL
Peterson	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Calabretta	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

94	NULL
,	NULL
8240-8244	NULL
Marhamati	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Bellas	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
Arsura	NULL
,	NULL
M.	NULL
,	NULL
Kypreos	NULL
,	NULL
K.	NULL
E.	NULL
,	NULL
and	NULL
Sonenshein	NULL
,	NULL
G.	NULL
E.	NULL
(	NULL
1997	NULL
)	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

Cell	NULL
,	NULL
in	NULL
press	NULL
Mettus	NULL
,	NULL
R.	NULL
V.	NULL
,	NULL
Litvin	NULL
,	NULL
J.	NULL
,	NULL
Wali	NULL
,	NULL
A.	NULL
,	NULL
Toscani	NULL
,	NULL
A.	NULL
,	NULL
Latham	NULL
,	NULL
K.	NULL
,	NULL
Hatton	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Reddy	NULL
,	NULL
E.	NULL
P.	NULL
(	NULL
1994	NULL
)	NULL
Oncogene	NULL
9	NULL
,	NULL
3077-3086	NULL
Toscani	NULL
,	NULL
A.	NULL
,	NULL
Mettus	NULL
,	NULL
R.	NULL
V.	NULL
,	NULL
Coupland	NULL
,	NULL
R.	NULL
,	NULL
Simpkins	NULL
,	NULL
H.	NULL
,	NULL
Litvin	NULL
,	NULL
J.	NULL
,	NULL
Orth	NULL
,	NULL
J.	NULL
,	NULL
Hatton	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
and	NULL
Reddy	NULL
,	NULL
E.	NULL
P.	NULL
(	NULL
1997	NULL
)	NULL
Nature	NULL
386	NULL
,	NULL
718-717	NULL
Facchinetti	NULL
,	NULL
V.	NULL
,	NULL
Loffarelli	NULL
,	NULL
L.	NULL
,	NULL
Schreek	NULL
,	NULL
S.	NULL
,	NULL
Oelgeschliiger	NULL
,	NULL
M.	NULL
,	NULL
Liischer	NULL
,	NULL
B.	NULL
,	NULL
Introna	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Golay	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Biochem	NULL
.	NULL

J	NULL
.	NULL

824	NULL
,	NULL
729-736	NULL
Takahashi	NULL
,	NULL
T.	NULL
,	NULL
Nakagoshi	NULL
,	NULL
H.	NULL
,	NULL
Sarai	NULL
,	NULL
A.	NULL
,	NULL
Nomura	NULL
,	NULL
N.	NULL
,	NULL
Yamamoto	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Ishii	NULL
,	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
FEBS	NULL
Lett	NULL
.	NULL

358	NULL
,	NULL
89-96	NULL
Golay	NULL
,	NULL
J.	NULL
,	NULL
Loffarelli	NULL
,	NULL
L.	NULL
,	NULL
Luppi	NULL
,	NULL
M.	NULL
,	NULL
Castellano	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Introna	NULL
,	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Oncogene	NULL
9	NULL
,	NULL
2469-2479	NULL
Seed	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Sheen	NULL
,	NULL
J.-Y	NULL
(	NULL
1988	NULL
)	NULL
Gene	NULL
(	NULL
Amst	NULL
.	NULL
)	NULL

67	NULL
,	NULL
270-277	NULL
Grasser	NULL
,	NULL
F.	NULL
A.	NULL
,	NULL
LaMontagne	NULL
,	NULL
K.	NULL
,	NULL
Whittaker	NULL
,	NULL
L.	NULL
,	NULL
Stohr	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Lipsick	NULL
,	NULL
J.	NULL
S.	NULL
(	NULL
1992	NULL
)	NULL
Oncogene	NULL
7	NULL
,	NULL
1005-1009	NULL
Webster	NULL
,	NULL
N.	NULL
,	NULL
Jin	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Green	NULL
,	NULL
S.	NULL
,	NULL
Hollis	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Chambon	NULL
,	NULL
P.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
52	NULL
,	NULL
169-178	NULL
Laughon	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Gesteland	NULL
,	NULL
R.	NULL
F.	NULL
(	NULL
1984	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

4	NULL
,	NULL
260-267	NULL
P.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
59	NULL
,	NULL
477-487	NULL
Golay	NULL
,	NULL
J.	NULL
,	NULL
Basilico	NULL
,	NULL
L.	NULL
,	NULL
Loffarelli	NULL
,	NULL
L.	NULL
,	NULL
Songia	NULL
,	NULL
S.	NULL
,	NULL
Broccoli	NULL
,	NULL
V.	NULL
,	NULL
and	NULL
Introna	NULL
,	NULL
M.	NULL
(	NULL
1996	NULL
)	NULL
Int	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Lab	NULL
.	NULL

Res	NULL
.	NULL

26	NULL
,	NULL
24-32	NULL
Ness	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Marknell	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Graf	NULL
,	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
59	NULL
,	NULL
1115-1125	NULL
Dash	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
,	NULL
Orrico	NULL
,	NULL
F.	NULL
C.	NULL
,	NULL
and	NULL
Ness	NULL
,	NULL
S.	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

10	NULL
,	NULL
1858-1869	NULL
Tong	NULL
,	NULL
X.	NULL
,	NULL
Drapkin	NULL
,	NULL
R.	NULL
,	NULL
Yalamanchili	NULL
,	NULL
R.	NULL
,	NULL
Mosialos	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Kieff	NULL
,	NULL
E.	NULL
(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
4785-4744	NULL
Martinez-Valdez	NULL
,	NULL
H.	NULL
,	NULL
Guret	NULL
,	NULL
C.	NULL
,	NULL
de	NULL
Bouteiller	NULL
,	NULL
O.	NULL
,	NULL
Fugier	NULL
,	NULL
I.	NULL
,	NULL
Banchereau	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Liu	NULL
,	NULL
Y.-J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

183	NULL
,	NULL
971-977	NULL
Magrath	NULL
,	NULL
I	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Adv	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

55	NULL
,	NULL
183-270	NULL
Kadesh	NULL
,	NULL
T.	NULL
(	NULL
1992	NULL
)	NULL
Immunol	NULL
.	NULL

Today	NULL
18	NULL
,	NULL
31-85	NULL
Strubin	NULL
,	NULL
M.	NULL
,	NULL
Newell	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
and	NULL
Matthias	NULL
,	NULL
P.	NULL
(	NULL
1995	NULL
)	NULL
Cell	NULL
80	NULL
,	NULL
497-506	NULL
Gstaiger	NULL
,	NULL
M.	NULL
,	NULL
Knoepfel	NULL
,	NULL
L.	NULL
,	NULL
Georgiev	NULL
,	NULL
O.	NULL
,	NULL
Schaffner	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Hovens	NULL
,	NULL
C.	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
Nature	NULL
878	NULL
,	NULL
360-362	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
The	NULL
DNA	NULL
Binding	NULL
Domain	NULL
of	NULL
the	NULL
A-MYB	NULL
Transcription	NULL
Factor	NULL
Is	NULL
Responsible	NULL
for	NULL
Its	NULL
B	NULL
Cell-specific	NULL
Activity	NULL
and	NULL
Binds	NULL
to	NULL
a	NULL
B	NULL
Cell	NULL
110-kDa	NULL
Nuclear	NULL
Protein	NULL
Guo-Guang	NULL
Ying	NULL
,	NULL
Marcello	NULL
Arsura	NULL
,	NULL
Martino	NULL
Introna	NULL
and	NULL
Josée	NULL
Golay	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1997	NULL
,	NULL
272:24921-24926.	NULL
doi	NULL
:	NULL
10.1074/jb0.272.40.24921	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/272/40/24921	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
32	NULL
references	NULL
,	NULL
10	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
.	NULL

full.html	NULL
#	NULL
ref-list-1	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL

